var title_f42_16_43264="Diagnosis and management of platelet refractoriness";
var content_f42_16_43264=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F73873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F73873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 633px\">",
"   <div class=\"ttl\">",
"    Diagnosis and management of platelet refractoriness",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 613px; height: 598px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43264=[""].join("\n");
var outline_f42_16_43264=null;
var title_f42_16_43265="Nifuroxazide: International drug information";
var content_f42_16_43265=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nifuroxazide: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4303789\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Akabar (MX);",
"     </li>",
"     <li>",
"      Antinal (BE, CH);",
"     </li>",
"     <li>",
"      Bacifurane (BE, LU);",
"     </li>",
"     <li>",
"      Bifix (FR);",
"     </li>",
"     <li>",
"      Diarret (IT);",
"     </li>",
"     <li>",
"      Ercefuryl (BE, ES, FR, IT, LU);",
"     </li>",
"     <li>",
"      Erceryl (FR);",
"     </li>",
"     <li>",
"      Eskapar (MX);",
"     </li>",
"     <li>",
"      Lumifurex (FR);",
"     </li>",
"     <li>",
"      Nifuroxazide EG (BE);",
"     </li>",
"     <li>",
"      Nifuroxazide-Eurogenerics (LU);",
"     </li>",
"     <li>",
"      Nifuroxazide-Ratiopharm (FR);",
"     </li>",
"     <li>",
"      Panfurex (FR, LU);",
"     </li>",
"     <li>",
"      Passifuril (BR);",
"     </li>",
"     <li>",
"      Pentofuryl (DE);",
"     </li>",
"     <li>",
"      Septidiaryl (FR);",
"     </li>",
"     <li>",
"      Topron (MX)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1979722\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidiarrheal",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1979725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of diarrhea",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1979721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 200 mg 4 times/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1979724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Capsule: 200 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Suspension, oral: 220 mg/5 mL",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10422 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-11D65C23BF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43265=[""].join("\n");
var outline_f42_16_43265=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303789\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979722\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979725\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979721\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821096\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979724\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10422\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10422|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_16_43266="Short axis tetralogy of Fallot";
var content_f42_16_43266=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1042px;\">",
"  <div class=\"videoplayer\" h264=\"./images/PEDS/73954/Short_axis_tetra_Fallot.mp4?title=Short+axis+tetralogy+of+Fallot\" style=\"width:432px;height:400px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 472px\">",
"   <div class=\"ttl\">",
"    Parasternal short axis view of tetralogy of Fallot (TOF)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 452px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This still frame from the accompanying echocardiographic video clip of the parasternal short axis view of a patient with tetralogy of Fallot (TOF) shows the boundaries of the ventricular septal defect (VSD). The VSD extends from the membranous septum, beneath the tricuspid valve, and into the outlet septum. The conal septum (CS) is intact in the suprascristal region and anteriorly deviated, separating the defect from the right ventricular outflow tract (RVOT). The video clip begins with these structures. The ultrasound transducer then sweeps apically through the ventricles, showing no other septal defects present in this patient.",
"    <div class=\"footnotes\">",
"     RA: right atrium; LA: left atrium; RV: right ventricle; LVOT: left ventricular outflow tract.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43266=[""].join("\n");
var outline_f42_16_43266=null;
var title_f42_16_43267="Chronic bullous disease of childhood";
var content_f42_16_43267=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Linear IgA bullous dermatosis of childhood (chronic bullous disease of childhood)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple tense bullae, crusts, and healing erosions are present. Note the annular configuration of several lesions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from:",
"     <a href=\"file://www.visualdx.com\" target=\"_blank\">",
"      www.visualdx.com",
"     </a>",
"     . Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43267=[""].join("\n");
var outline_f42_16_43267=null;
var title_f42_16_43268="Skin nodule associated with Staphyloccoccus aureus infection";
var content_f42_16_43268=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Skin nodule associated with Staphyloccoccus aureus infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sheldon Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43268=[""].join("\n");
var outline_f42_16_43268=null;
var title_f42_16_43269="Sodium polystyrene sulfonate: Drug information";
var content_f42_16_43269=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sodium polystyrene sulfonate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?21/62/22500?source=see_link\">",
"    see \"Sodium polystyrene sulfonate: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/38/5733?source=see_link\">",
"    see \"Sodium polystyrene sulfonate: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F222030\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Kalexate;",
"     </li>",
"     <li>",
"      Kayexalate&reg;;",
"     </li>",
"     <li>",
"      Kionex&reg;;",
"     </li>",
"     <li>",
"      SPS&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F222031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Kayexalate&reg;;",
"     </li>",
"     <li>",
"      PMS-Sodium Polystyrene Sulfonate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F222046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidote",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F222033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hyperkalemia:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: 15 g 1-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rectal: 30-50 g every 6 hours",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F222042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/38/5733?source=see_link\">",
"      see \"Sodium polystyrene sulfonate: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hyperkalemia:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Children: 1 g/kg/dose every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rectal: Children: 1 g/kg/dose every 2-6 hours (in small children and infants, employ lower doses by using the practical exchange ratio of 1 mEq K",
"     <sup>",
"      +",
"     </sup>",
"     /g of resin as the basis for calculation)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F222034\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F222010\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral/rectal:  (454 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kalexate:  (454 g) [contains sodium 100 mg (4.1 mEq)/g]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kayexalate&reg;:  (454 g) [contains sodium 100 mg (4.1 mEq)/g]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kionex&reg;:  (454 g) [contains sodium 100 mg (4.1 mEq)/g]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, oral/rectal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kionex&reg;: 15 g/60 mL (60 mL, 480 mL) [contains ethanol 0.2%, propylene glycol, sodium 1500 mg (65 mEq)/60 mL, sorbitol; raspberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SPS&reg;: 15 g/60 mL (60 mL, 120 mL, 473 mL) [contains ethanol 0.3%, propylene glycol, sodium 1500 mg (65 mEq)/60 mL, sorbitol; cherry flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F221996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Powder for suspension",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F222015\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Shake suspension well prior to administration. Administer orally (or via NG tube)  as a suspension.",
"     <b>",
"      Do not mix in orange juice.",
"     </b>",
"     Chilling the oral mixture will increase palatability.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Powder for suspension: For each 1 g of the powdered resin, add 3-4 mL of water or syrup (amount of fluid usually ranges from 20-100 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rectal: Enema route is less effective than oral administration. Administer cleansing enema first. Each dose of the powder for suspension should be suspended in 100 mL of aqueous vehicle and administered as a warm emulsion (body temperature). The commercially available suspension should also be warmed to body temperature. During administration, the solution should be agitated gently. Retain enema in colon for at least 30-60 minutes and for several hours, if possible. Once retention time is complete, irrigate colon with a nonsodium-containing solution to remove resin.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F222014\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of hyperkalemia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F222054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Kayexalate&reg; may be confused with Kaopectate&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Sodium polystyrene sulfonate may be confused with calcium polystyrene sulfonate",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Always prescribe either one-time doses or as a specific number of doses (eg, 15 g q6h x 2 doses). Scheduled doses with no dosage limit could be given for days leading to dangerous hypokalemia.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Kionex [U.S.] may be confused with Kinex brand name for biperiden [Mexico]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F222044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Frequency not defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypernatremia, hypocalcemia, hypokalemia, hypomagnesemia, sodium retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, constipation, diarrhea, fecal impaction, intestinal necrosis (rare), intestinal obstruction (due to concretions in association with aluminum hydroxide), nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Acute bronchitis (rare; associated with inhalation of particles), concretions, gastrointestinal bleeding, gastrointestinal ulceration, intestinal perforation, ischemic colitis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F222018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to sodium polystyrene sulfonate or any component of the formulation; hypokalemia; obstructive bowel disease; neonates with reduced gut motility (postoperatively or drug-induced); oral administration in neonates",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Additional contraindications: Sodium polystyrene sulfonate suspension (",
"     <b>",
"      with",
"     </b>",
"     sorbitol): Rectal administration in neonates (particularly in premature infants); any postoperative patient until normal bowel function resumes",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F222000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electrolyte disturbances: In addition to serum potassium-lowering effects, cation-exchange resins may also affect other cation concentrations possibly resulting in decreased serum magnesium and calcium.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fecal impaction: Large oral doses may cause fecal impaction (especially in elderly); rectal administration has been associated with fecal impaction in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypokalemia: Severe hypokalemia may occur; frequent monitoring of serum potassium is recommended within each 24-hour period; ECG monitoring may be appropriate in select patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Intestinal necrosis: Intestinal necrosis (including fatalities) and other serious gastrointestinal events (eg, bleeding, ischemic colitis, perforation) have been reported, especially when administered with sorbitol. Increased risk may be associated with a history of intestinal disease or surgery, hypovolemia, prematurity, and renal insufficiency or failure. Avoid use in any postoperative patient until normal bowel function resumes or in patients at risk for constipation or impaction; discontinue use if constipation occurs. Oral or rectal administration of sorbitol-containing sodium polystyrene sulfonate suspensions is contraindicated in neonates (particularly with prematurity).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with severe heart failure and/or hypertension; sodium load may exacerbate condition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Edema: Use with caution in patients with edema; sodium load may exacerbate condition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Antacids/laxative: Concomitant administration of oral sodium polystyrene sulfonate with nonabsorbable cation-donating antacids or laxatives (eg, magnesium hydroxide) may result in systemic alkalosis and may diminish ability to reduce serum potassium concentrations; use with such agents is not recommended. In addition, intestinal obstruction has been reported with concomitant administration of aluminum hydroxide due to concretion formation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sorbitol: Concomitant use of sorbitol is associated with an increased risk of intestinal necrosis and other serious gastrointestinal events (eg, bleeding, ischemic colitis, perforation); use with sorbitol is not recommended. Use caution with sorbitol-containing sodium polystyrene sulfonate suspensions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Higher doses in elderly patients may result in fecal impaction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Oral administration in neonates and use in neonates with reduced gut motility (postoperatively or drug-induced) is contraindicated. Oral or rectal administration of sorbitol-containing sodium polystyrene sulfonate suspensions in neonates (particularly with prematurity) is also contraindicated due to propylene glycol content and risk of intestinal necrosis and digestive hemorrhage. Use sodium polystyrene sulfonate (",
"     <b>",
"      without",
"     </b>",
"     sorbitol) with caution in premature or low-birth-weight infants. Use with caution in children when administering rectally; excessive dosage or inadequate dilution may result in fecal impaction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Effective lowering of serum potassium from sodium polystyrene sulfonate may take hours to days after administration; consider alternative measures (eg, dialysis) or concomitant therapy (eg, I.V. sodium bicarbonate) in situations where rapid correction of severe hyperkalemia is required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Enema vs oral administration: Enema will reduce the serum potassium faster than oral administration, but the oral route will result in a greater reduction over several hours.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F222004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aluminum Hydroxide: Sodium Polystyrene Sulfonate may enhance the adverse/toxic effect of Aluminum Hydroxide. More specifically, concomitant use of these agents  may increase the risk for intestinal obstruction.  Management: Monitor for signs/symptoms of intestinal obstruction with concomitant use of calcium polystyrene sulfonate and aluminum hydroxide. Adequate fluid intake, laxative use, alternative antacid agents, and/or limiting duration of therapy may help reduce risks.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the exchange resin. Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of SPS effects. Avoid magnesium hydroxide.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Sodium Bicarbonate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Digoxin: Sodium Polystyrene Sulfonate may enhance the adverse/toxic effect of Digoxin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Laxatives: May enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. More specifically, concomitant use of sodium polystyrene sulfonate with magnesium-containing laxatives may result in metabolic alkalosis or with sorbitol may result in intestinal necrosis. Management: Avoid concomitant use of sodium polystyrene sulfonate (rectal or oral) and magnesium-containing laxatives or sorbitol.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bisacodyl; Dehydrocholic Acid; Lactulose; Polycarbophil; Psyllium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Sodium Polystyrene Sulfonate may decrease the serum concentration of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Meloxicam: May enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. More specifically, concomitant use of meloxicam oral suspension (which contains sorbitol) may increase the risk for intestinal necrosis.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sorbitol: May enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. More specifically, concomitant use of these agents may increase the risk for intestinal necrosis.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: Sodium Polystyrene Sulfonate may decrease the serum concentration of Thyroid Products.  Management: To minimize risk of interaction, separate dosing of oral sodium polystyrene sulfonate and thyroid products (e.g., levothyroxine) or administer sodium polystyrene sulfonate rectally. Monitor for signs/symptoms of hypothyroidism with concomitant use (oral).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F13851578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Some liquids may contain potassium: Management: Do not mix in orange juice or in any fruit juice known to contain potassium.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F222006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F11510210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if benefits outweigh the risks.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F222038\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F222022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do",
"     <b>",
"      not",
"     </b>",
"     mix in orange juice or in any fruit juice known to contain potassium. Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F222021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Kionex Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 g/60 mL (60 mL): $8.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Sodium Polystyrene Sulfonate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 g/60 mL (60 mL): $8.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (SPS Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 g/60 mL (120 mL): $44.10",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F222008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum electrolytes (potassium, sodium, calcium, magnesium); ECG in select patients",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F222011\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum potassium: Adults: 3.5-5.2 mEq/L",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F222023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Kayexalate (BB, BE, BM, BS, BZ, FR, GY, IL, IT, JM, SR, TH, TT);",
"     </li>",
"     <li>",
"      Kexelate (ZA);",
"     </li>",
"     <li>",
"      Kuzem (TW);",
"     </li>",
"     <li>",
"      Resinsodio (SG);",
"     </li>",
"     <li>",
"      Resonium (DK, FI, PT, SE);",
"     </li>",
"     <li>",
"      Resonium A (AT, AU, GB, HK, HN, MY, NL, TW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F221999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Removes potassium by exchanging sodium ions for potassium ions in the intestine (especially the large intestine) before the resin is passed from the body; exchange capacity is 1 mEq/g",
"     <i>",
"      in vivo",
"     </i>",
"     , and",
"     <i>",
"      in vitro",
"     </i>",
"     capacity is 3.1 mEq/g, therefore, a wide range of exchange capacity exists such that close monitoring of serum electrolytes is necessary",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F222017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 2-24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: None",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Completely feces (primarily as potassium polystyrene sulfonate)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Belanger DR, Tierney MG, and Dickinson G, &ldquo;Effect of Sodium Polystyrene Sulfonate on Lithium Bioavailability,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1992, 21(11):1312-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/16/43269/abstract-text/1416324/pubmed\" id=\"1416324\" target=\"_blank\">",
"        1416324",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Haupt HM and Hutchins GM, &ldquo;Sodium Polystyrene Sulfonate Pneumonitis,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1982, 142(2):379-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/16/43269/abstract-text/7059266/pubmed\" id=\"7059266\" target=\"_blank\">",
"        7059266",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Malone TA, &ldquo;Glucose and Insulin Versus Cation-Exchange Resin for the Treatment of Hyperkalemia in Very Low Birth Weight Infants,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1991, 118(1):121-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/16/43269/abstract-text/1986079/pubmed\" id=\"1986079\" target=\"_blank\">",
"        1986079",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McGowan CE, Saha S, Chu G, et al, &ldquo;Intestinal Necrosis Due to Sodium Polystyrene Sulfonate (Kayexalate) in Sorbitol,&rdquo;",
"      <i>",
"       South Med J",
"      </i>",
"      , 2009, 102(5):493-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/16/43269/abstract-text/19373153/pubmed\" id=\"19373153\" target=\"_blank\">",
"        19373153",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/16/43269/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tomaszewski C, Musso C, Pearson JR, et al, &ldquo;Lithium Absorption Prevented by Sodium Polystyrene Sulfonate in Volunteers,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1992, 21(11):1308-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/16/43269/abstract-text/1416323/pubmed\" id=\"1416323\" target=\"_blank\">",
"        1416323",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9936 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-76D4E16EBB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43269=[""].join("\n");
var outline_f42_16_43269=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222030\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222031\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222046\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222033\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222042\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222034\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222010\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221996\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222015\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222014\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222054\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222044\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222018\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222000\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300068\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222004\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13851578\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222006\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11510210\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222038\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222022\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222021\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222008\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222011\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222023\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221999\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222017\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9936\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9936|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?21/62/22500?source=related_link\">",
"      Sodium polystyrene sulfonate: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/38/5733?source=related_link\">",
"      Sodium polystyrene sulfonate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_16_43270="LV RV diastolic pressures";
var content_f42_16_43270=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Right and left ventricular end-diastolic pressure tracings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 279px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Simultaneous right (RV) and left ventricular (LV) pressures recordings. Panel A: A normal patient who has a junctional rhythm, accounting for the absence of the \"a\" wave at the end of diastole. Although the diastolic period is relatively flat for the first beat, there is normal filling by the third beat. Panel B: Elevated left ventricular end-diastolic pressure (LVEDP) in patient with impaired LV relaxation and diastolic dysfunction due to chronic mitral regurgitation. Panel C: Recorded at a scale of 0 to 100 mmHg in a patient with decompensated severe heart failure. The LVEDP is significantly elevated and there is also elevation of the right ventricular end diastolic pressure (RVEDP). In addition, the upstroke velocity of LV systole is delayed, consistent with global LV dysfunction. Panel D: Elevations in both RVEDP and LVEDP due to a cardiomyopathy. A ventricular pacemaker is also present, causing a delay and skewing in the RV diastolic relaxation period with overlapping of the LV and RV pressure downslopes. Panel E: A patient with hypertension and heart failure who has a left bundle branch block. The LVEDP is elevated and the LV pressure upslope in systole is more rapid than that of the RV. The LV is noncompliant, resulting in a rapid increase in diastolic pressure which is not seen in the RV. As in panel D, RV diastolic relaxation is delayed and overlaps with that of the LV.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Kern, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43270=[""].join("\n");
var outline_f42_16_43270=null;
var title_f42_16_43271="Bacteriology and epidemiology of Helicobacter pylori infection";
var content_f42_16_43271=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bacteriology and epidemiology of Helicobacter pylori infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/16/43271/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43271/contributors\">",
"     Sheila E Crowe, MD, FRCPC, FACP, FACG, AGAF",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/16/43271/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43271/contributors\">",
"     Mark Feldman, MD, MACP, AGAF, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/16/43271/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43271/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/16/43271/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric organisms were first observed more than 100 years ago and their association with gastritis has been recognized since the 1970s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/1\">",
"     1",
"    </a>",
"    ]. The true implication of these microbes was not fully realized, however, until 1982 when Marshall and Warren identified and subsequently cultured the gastric bacterium,",
"    <em>",
"     Campylobacter pyloridis",
"    </em>",
"    , later reclassified as",
"    <em>",
"     Helicobacter pylori",
"    </em>",
"    (",
"    <em>",
"     H. pylori",
"    </em>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/2\">",
"     2",
"    </a>",
"    ]. This organism is now known to cause chronic gastritis, most peptic ulcers, and gastric adenocarcinoma and lymphoma. (See appropriate topic reviews.)",
"   </p>",
"   <p>",
"    The bacteriology and epidemiology of",
"    <em>",
"     H. pylori",
"    </em>",
"    will be reviewed here. Understanding its bacteriology and the unique features that enable it to survive in an environment as hostile as the stomach are important in appreciating how",
"    <em>",
"     H. pylori",
"    </em>",
"    causes tissue injury and clinical disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/44/4809?source=see_link\">",
"     \"Pathophysiology of and immune response to Helicobacter pylori infection\"",
"    </a>",
"    .) The epidemiology of this infection sheds light on the geographic, ethnic, and racial differences in prevalence of",
"    <em>",
"     H. pylori",
"    </em>",
"    -associated diseases and the changing incidence of these conditions throughout the world.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACTERIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Microbiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     H. pylori",
"    </em>",
"    is a spiral shaped, microaerophilic, gram negative bacterium measuring approximately 3.5 microns in length and 0.5 microns in width (",
"    <a class=\"graphic graphic_picture graphicRef74689 \" href=\"mobipreview.htm?14/44/15043\">",
"     picture 1",
"    </a>",
"    ). In vitro, it is a slow growing organism that can be cultured on blood agar or selective media such as Skirrow's media incubated at 37&ordm;C in a 5 percent oxygen atmosphere for three to seven days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/3\">",
"     3",
"    </a>",
"    ]. Small, uniformly sized, translucent bacterial colonies form and the organisms can be morphologically characterized by Gram stain and their typical spiral or rod shaped appearance. High power microscopy reveals that the organism has two to seven unipolar sheathed flagella which enhance its mobility through viscous solutions.",
"   </p>",
"   <p>",
"    If the growth environment is less than ideal, coccoid forms of",
"    <em>",
"     H. pylori",
"    </em>",
"    can occasionally be seen in culture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/3\">",
"     3",
"    </a>",
"    ]. These coccoid forms are thought to represent an adaptation to hostile surroundings; they appear to be more resistant and may enable the organism to survive for periods of time outside the human host in feces or in drinking water.",
"   </p>",
"   <p>",
"    In addition to morphologic characterization, the organism can be biochemically characterized as catalase, oxidase, and urease positive. Urease appears to be vital for its survival and colonization; it is produced in abundance, making up more than 5 percent of the organism's total protein weight. Bacterial urease activity is clinically important because it forms the basis for several invasive and noninvasive tests to diagnose infection (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37817?source=see_link\">",
"     \"Indications and diagnostic tests for Helicobacter pylori infection\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Gastric adaptation of H. pylori",
"    </span>",
"    &nbsp;&mdash;&nbsp;The organism's urease, motility, and ability to adhere to gastric epithelium are factors that allow it to survive and proliferate in the gastric milieu [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/4\">",
"     4",
"    </a>",
"    ]. Disruption of urease activity, bacterial mobility, or attachment prevents",
"    <em>",
"     H. pylori",
"    </em>",
"    colonization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/5\">",
"     5",
"    </a>",
"    ]. The interactions of",
"    <em>",
"     H. pylori",
"    </em>",
"    proteins underlying these activities are rapidly being uncovered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bacterial urease hydrolyzes gastric luminal urea to form ammonia that helps neutralize gastric acid and form a protective cloud around the organism, enabling it to penetrate the gastric mucus layer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/8\">",
"       8",
"      </a>",
"      ]. A specific gene (ureI) exists within",
"      <em>",
"       H. pylori",
"      </em>",
"      's urease gene cluster that encodes for a pH dependent urea channel [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/9\">",
"       9",
"      </a>",
"      ]. As the pH outside the organism drops, the urea channel permits internal movement of urea to maintain a favorable intracellular pH, allowing the bacterium to survive in an acid milieu.",
"     </li>",
"     <li>",
"      Its spiral shape, flagella, and the mucolytic enzymes which it produces facilitate its passage through the mucus layer to the gastric surface epithelium [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/3\">",
"       3",
"      </a>",
"      ]. On the other hand, gastric mucin appears to serve as a natural antibiotic, protecting the host against",
"      <em>",
"       H. pylori",
"      </em>",
"      infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <em>",
"       H. pylori",
"      </em>",
"      then attaches to gastric epithelial cells by means of specific receptor-mediated adhesion (",
"      <a class=\"graphic graphic_picture graphicRef63916 graphicRef58872 \" href=\"mobipreview.htm?19/23/19832\">",
"       picture 2A-B",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/5,11\">",
"       5,11",
"      </a>",
"      ]. Although attachment is dependent upon binding of bacterial surface adhesins to specific epithelial cell receptors, host factors can modulate this process. As an example, certain individuals may express specific surface receptors or greater numbers of receptors, making them more susceptible to",
"      <em>",
"       H. pylori",
"      </em>",
"      attachment and colonization [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     H. pylori",
"    </em>",
"    is the most common chronic bacterial infection in humans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Studies involving genetic sequence analysis suggest that humans have been infected with",
"    <em>",
"     H. pylori",
"    </em>",
"    since they first migrated from Africa around 58,000 years ago [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/15\">",
"     15",
"    </a>",
"    ].",
"    <em>",
"     H. pylori",
"    </em>",
"    has been demonstrated worldwide and in individuals of all ages. Conservative estimates suggest that 50 percent of the world's population is affected. Infection is more frequent and acquired at an earlier age in developing countries compared with industrialized nations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/14\">",
"     14",
"    </a>",
"    ]. Once acquired, infection persists and may or may not produce gastroduodenal disease.",
"   </p>",
"   <p>",
"    In developing nations, where the majority of children are infected before the age of 10, the prevalence in adults peaks at more than 80 percent before age 50 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/14,16\">",
"     14,16",
"    </a>",
"    ]. In developed countries, such as the United States, evidence of infection in children is unusual but becomes more common during adulthood. Serologic evidence of",
"    <em>",
"     H. pylori",
"    </em>",
"    is rarely found before age 10 but increases to 10 percent in those between 18 and 30 years of age and to 50 percent in those older than age 60 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/14\">",
"     14",
"    </a>",
"    ]. Within any age group, infection appears to be more common in blacks and Hispanics compared to the white population; these differences are probably in part related to socioeconomic factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The increased prevalence of infection with age was initially thought to represent a continuing rate of bacterial acquisition throughout one's lifetime. However, epidemiologic evidence now indicates most infections are acquired during childhood even in developed countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/14,19\">",
"     14,19",
"    </a>",
"    ]. Most infections were acquired before five years of age with a declining incidence thereafter in one report from Ireland [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/20\">",
"     20",
"    </a>",
"    ]. Thus, the frequency of",
"    <em>",
"     H. pylori",
"    </em>",
"    infection for any age group in any locality reflects that particular cohort's rate of bacterial acquisition during childhood years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/19\">",
"     19",
"    </a>",
"    ]. The organisms can be cultured from vomitus or diarrheal stools suggesting the potential for transmission among family members during periods of illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of acquiring",
"    <em>",
"     H. pylori",
"    </em>",
"    infection is related to socioeconomic status and living conditions early in life. Factors such as density of housing, overcrowding, number of siblings, sharing a bed, and lack of running water have all been linked to a higher acquisition rate of",
"    <em>",
"     H. pylori",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. More recent studies continue to show that in developing countries such as Iran, childhood hygiene practices and family education determine the prevalence of",
"    <em>",
"     H. pylori",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/26\">",
"     26",
"    </a>",
"    ]. The association of",
"    <em>",
"     H. pylori",
"    </em>",
"    infection with level of education, income, and",
"    <span class=\"nowrap\">",
"     race/ethnicity",
"    </span>",
"    is not unique to",
"    <em>",
"     H. pylori",
"    </em>",
"    since similar associations have been described with other chronic infections including cytomegalovirus, herpes simplex virus-1 and hepatitis B [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/27\">",
"     27",
"    </a>",
"    ]. Within a particular country, a decline in prevalence of",
"    <em>",
"     H. pylori",
"    </em>",
"    appears to parallel economic improvement. In Japan, for example, 70 to 80 percent of adults born before 1950, 45 percent of those born between 1950 and 1960, and 25 percent of those born between 1960 and 1970 are infected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/28\">",
"     28",
"    </a>",
"    ]. This rapid decline of infection has been attributed to Japan's post-war economic progress and improvement in sanitation.",
"   </p>",
"   <p>",
"    The consumption of salted food appears to increase the possibility of persistent infection with",
"    <em>",
"     H. pylori",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In addition, a synergistic interaction between",
"    <em>",
"     H. pylori",
"    </em>",
"    infection and salted food intake to increase the risk of gastric cancer has also been reported in case-control studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/38/618?source=see_link\">",
"     \"Risk factors for gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Possible hereditary susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary susceptibility to",
"    <em>",
"     H. pylori",
"    </em>",
"    infection has not been proven. However, studies do suggest that members of certain ethnic and racial groups including Hispanics and African-Americans have a higher rate of infection than Caucasians. These differences are not entirely explained by differences in socioeconomic status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Twin studies also support genetic susceptibility to infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Monozygotic twins raised in different households have a greater concordance of",
"    <em>",
"     H. pylori",
"    </em>",
"    infection than do dizygotic twins raised apart. However, twins raised together have a higher concordance of",
"    <em>",
"     H. pylori",
"    </em>",
"    status than twins raised separately, emphasizing the role of childhood environment in",
"    <em>",
"     H. pylori",
"    </em>",
"    acquisition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     H. pylori transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;The route by which infection occurs remains unknown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/13,36\">",
"     13,36",
"    </a>",
"    ]. Person-to-person transmission of",
"    <em>",
"     H. pylori",
"    </em>",
"    through either",
"    <span class=\"nowrap\">",
"     fecal/oral",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     oral/oral",
"    </span>",
"    exposure seems most likely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/22,36\">",
"     22,36",
"    </a>",
"    ]. Humans appear to be the major reservoir of infection; however,",
"    <em>",
"     H. pylori",
"    </em>",
"    has been isolated from primates in captivity and from domestic cats [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/37\">",
"     37",
"    </a>",
"    ]. It is unclear how these animals originally acquired",
"    <em>",
"     H. pylori",
"    </em>",
"    infection. However, at least in the case of cats, isolation of viable organisms from saliva and gastric juice samples suggests that transmission to humans might occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/38\">",
"     38",
"    </a>",
"    ]. One report described the identification of",
"    <em>",
"     H. pylori",
"    </em>",
"    in milk and gastric tissue of sheep suggesting that sheep may be a natural host for the organism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/39\">",
"     39",
"    </a>",
"    ]. This may explain the higher infection rate that has been observed among shepherds compared to their siblings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Fecal/oral",
"    </span>",
"    transmission of bacteria is also possible. Contaminated water supplies in developing countries may serve as an environmental source of bacteria. The organism remains viable in water for several days and, using polymerase chain reaction techniques, evidence of",
"    <em>",
"     H. pylori",
"    </em>",
"    can be found in most samples of municipal water from endemic areas of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. Children who regularly swim in rivers, streams, pools, drink stream water, or eat uncooked vegetables are more likely to be infected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/44\">",
"     44",
"    </a>",
"    ].",
"    <em>",
"     H. pylori",
"    </em>",
"    has been cultured from diarrheal stools of children in The Gambia, West Africa where almost all inhabitants are infected by five years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intrafamilial clustering of infection further supports person-to-person transmission. Infected individuals are more likely to have infected spouses and children than uninfected individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/25,46\">",
"     25,46",
"    </a>",
"    ]. A study of children in Columbia found that the risk of infection correlated directly with the number of children aged 2 to 9 in the household while younger children were more likely to be infected if older siblings were also infected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/47\">",
"     47",
"    </a>",
"    ]. Isolation of genetically identical strains of",
"    <em>",
"     H. pylori",
"    </em>",
"    from multiple family members [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/48\">",
"     48",
"    </a>",
"    ] as well as custodial patients in the same institution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/49\">",
"     49",
"    </a>",
"    ] further supports transmission among persons sharing the same living environment. In addition to the familial type of transmission that occurs in developed and other nations, horizontal transmission between persons who do not belong to a core family also appears to take place in countries where the prevalence of infection is high [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Oral/oral",
"    </span>",
"    transmission of bacteria has yet to be confirmed. Organisms have been identified in dental plaque [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/51\">",
"     51",
"    </a>",
"    ], but the prevalence can be quite low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/52\">",
"     52",
"    </a>",
"    ] so it is not known if this location can serve as a source or reservoir. Dentists and oral hygienists who have continual occupational exposure to dental plaque do not have a higher prevalence of",
"    <em>",
"     H. pylori",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/53\">",
"     53",
"    </a>",
"    ]. On the other hand, infected gastric secretions can serve as a source of bacterial transmission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Iatrogenic infection has been documented following the use of a variety of inadequately disinfected gastric devices, endoscopes, and endoscopic accessories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/55\">",
"     55",
"    </a>",
"    ]. In addition, gastroenterologists and nurses appear to be at increased risk for acquiring",
"    <em>",
"     H. pylori",
"    </em>",
"    ; this is presumably due to occupational exposure to infected gastric secretions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/23\">",
"     23",
"    </a>",
"    ]. Mandated universal precautions, standardized equipment disinfection, and use of video-endoscopes which remove the instrument channel away from the mouth should reduce occupational and iatrogenic",
"    <em>",
"     H. pylori",
"    </em>",
"    transmission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Reinfection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reinfection with",
"    <em>",
"     H. pylori",
"    </em>",
"    following successful bacterial cure is unusual. Recurrence of infection most commonly represents recrudescence of the original bacterial strain. In adults, reacquisition of bacteria occurs in less than 2 percent of persons per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/56,57\">",
"     56,57",
"    </a>",
"    ], a rate that is similar to primary adult acquisition of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/19\">",
"     19",
"    </a>",
"    ]. The low reinfection rate in adults supports the lower risk for infection during adulthood, although acquired immunity conferred by primary infection may also be important.",
"   </p>",
"   <p>",
"    It has been hypothesized that the reinfection rates may be higher in children, in developing countries, and in those from low socioeconomic status. However, a study from China found that the reinfection rates were comparable to reports from the west (annual recurrence rate of 1 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/58\">",
"     58",
"    </a>",
"    ]. Similarly, another report found a low annual reinfection rate (2 percent) in children older than five, regardless of socioeconomic status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43271/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/31/19954?source=see_link\">",
"       \"Patient information: H. pylori infection (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/58/14242?source=see_link\">",
"       \"Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100820650\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <em>",
"       Helicobacter pylori",
"      </em>",
"      (",
"      <em>",
"       H. pylori",
"      </em>",
"      ) is a spiral shaped, microaerophilic, gram negative bacterium measuring approximately 3.5 microns in length and 0.5 microns in width. The organism has two to seven unipolar sheathed flagella which enhance its mobility through viscous solutions. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Bacteriology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The organism can be biochemically characterized as catalase, oxidase, and urease positive. Urease appears to be vital for its survival and colonization; it is produced in abundance, making up more than 5 percent of the organism's total protein weight. Bacterial urease activity is clinically important because it forms the basis for several invasive and noninvasive tests to diagnose infection. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <em>",
"       H. pylori",
"      </em>",
"      has been demonstrated worldwide and in individuals of all ages. Conservative estimates suggest that 50 percent of the world's population is affected. Infection is more frequent and acquired at an earlier age in developing countries compared with industrialized nations. Once acquired, infection persists and may or may not produce gastroduodenal disease. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of acquiring",
"      <em>",
"       H. pylori",
"      </em>",
"      infection is related to socioeconomic status and living conditions early in life. Factors such as density of housing, overcrowding, number of siblings, sharing a bed, and lack of running water have all been linked to a higher acquisition rate of",
"      <em>",
"       H. pylori",
"      </em>",
"      infection. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The route by which infection occurs remains unknown. Person-to-person transmission of",
"      <em>",
"       H. pylori",
"      </em>",
"      through either",
"      <span class=\"nowrap\">",
"       fecal/oral",
"      </span>",
"      or",
"      <span class=\"nowrap\">",
"       oral/oral",
"      </span>",
"      exposure seems most likely. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'H. pylori transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reinfection with",
"      <em>",
"       H. pylori",
"      </em>",
"      following successful bacterial cure is unusual. Recurrence of infection most commonly represents recrudescence of the original bacterial strain. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Reinfection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Marshall BJ. History of the discovery of C. pylori. In: Campylobacter Pylori in Gastritis and Peptic Ulcer Disease, Blaser MJ (Ed), Igaku-Shoin, New York 1989. p.7.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/2\">",
"      Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/3\">",
"      Goodwin CS, Worsley BW. Microbiology of Helicobacter pylori. Gastroenterol Clin North Am 1993; 22:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/4\">",
"      Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008; 134:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/5\">",
"      Mobley HL. Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. Am J Med 1996; 100:2S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/6\">",
"      Rain JC, Selig L, De Reuse H, et al. The protein-protein interaction map of Helicobacter pylori. Nature 2001; 409:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/7\">",
"      Ernst PB, Peura DA, Crowe SE. The translation of Helicobacter pylori basic research to patient care. Gastroenterology 2006; 130:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/8\">",
"      Mobley HL. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Aliment Pharmacol Ther 1996; 10 Suppl 1:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/9\">",
"      Weeks DL, Eskandari S, Scott DR, Sachs G. A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 2000; 287:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/10\">",
"      Kawakubo M, Ito Y, Okimura Y, et al. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 2004; 305:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/11\">",
"      Logan RP. Adherence of Helicobacter pylori. Aliment Pharmacol Ther 1996; 10 Suppl 1:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/12\">",
"      Wadstr&ouml;m T, Hirmo S, Bor&eacute;n T. Biochemical aspects of Helicobacter pylori colonization of the human gastric mucosa. Aliment Pharmacol Ther 1996; 10 Suppl 1:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/13\">",
"      Cave DR. Transmission and epidemiology of Helicobacter pylori. Am J Med 1996; 100:12S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/14\">",
"      Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9 Suppl 2:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/15\">",
"      Linz B, Balloux F, Moodley Y, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007; 445:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/16\">",
"      Torres J, Leal-Herrera Y, Perez-Perez G, et al. A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis 1998; 178:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/17\">",
"      Smoak BL, Kelley PW, Taylor DN. Seroprevalence of Helicobacter pylori infections in a cohort of US Army recruits. Am J Epidemiol 1994; 139:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/18\">",
"      Everhart JE, Kruszon-Moran D, Perez-Perez GI, et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 2000; 181:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/19\">",
"      Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9 Suppl 2:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/20\">",
"      Rowland M, Daly L, Vaughan M, et al. Age-specific incidence of Helicobacter pylori. Gastroenterology 2006; 130:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/21\">",
"      Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 1999; 282:2240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/22\">",
"      Perry S, de la Luz Sanchez M, Yang S, et al. Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg Infect Dis 2006; 12:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/23\">",
"      Hunt RH, Sumanac K, Huang JQ. Review article: should we kill or should we save Helicobacter pylori? Aliment Pharmacol Ther 2001; 15 Suppl 1:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/24\">",
"      Webb PM, Knight T, Greaves S, et al. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 1994; 308:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/25\">",
"      Kivi M, Johansson AL, Reilly M, Tindberg Y. Helicobacter pylori status in family members as risk factors for infection in children. Epidemiol Infect 2005; 133:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/26\">",
"      Nouraie M, Latifi-Navid S, Rezvan H, et al. Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter 2009; 14:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/27\">",
"      Zajacova A, Dowd JB, Aiello AE. Socioeconomic and race/ethnic patterns in persistent infection burden among U.S. adults. J Gerontol A Biol Sci Med Sci 2009; 64:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/28\">",
"      Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/29\">",
"      Tsugane S, Tei Y, Takahashi T, et al. Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res 1994; 85:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/30\">",
"      Fox JG, Dangler CA, Taylor NS, et al. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 1999; 59:4823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/31\">",
"      Lee SA, Kang D, Shim KN, et al. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 2003; 13:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/32\">",
"      Machida-Montani A, Sasazuki S, Inoue M, et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer 2004; 7:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/33\">",
"      Graham DY, Malaty HM, Evans DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/34\">",
"      Malaty HM, Engstrand L, Pedersen NL, Graham DY. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 1994; 120:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/35\">",
"      Riccardi VM, Rotter JI. Familial Helicobacter pylori infection. Societal factors, human genetics, and bacterial genetics. Ann Intern Med 1994; 120:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/36\">",
"      M&eacute;graud F. Transmission of Helicobacter pylori: faecal-oral versus oral-oral route. Aliment Pharmacol Ther 1995; 9 Suppl 2:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/37\">",
"      Fox JG. Non-human reservoirs of Helicobacter pylori. Aliment Pharmacol Ther 1995; 9 Suppl 2:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/38\">",
"      Handt LK, Fox JG, Dewhirst FE, et al. Helicobacter pylori isolated from the domestic cat: public health implications. Infect Immun 1994; 62:2367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/39\">",
"      Dore MP, Sepulveda AR, El-Zimaity H, et al. Isolation of Helicobacter pylori from sheep-implications for transmission to humans. Am J Gastroenterol 2001; 96:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/40\">",
"      Dore MP, Bilotta M, Vaira D, et al. High prevalence of Helicobacter pylori infection in shepherds. Dig Dis Sci 1999; 44:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/41\">",
"      Hulten K, Han SW, Enroth H, et al. Helicobacter pylori in the drinking water in Peru. Gastroenterology 1996; 110:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/42\">",
"      Bellack NR, Koehoorn MW, MacNab YC, Morshed MG. A conceptual model of water's role as a reservoir in Helicobacter pylori transmission: a review of the evidence. Epidemiol Infect 2006; 134:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/43\">",
"      Queralt N, Bartolom&eacute; R, Araujo R. Detection of Helicobacter pylori DNA in human faeces and water with different levels of faecal pollution in the north-east of Spain. J Appl Microbiol 2005; 98:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/44\">",
"      Goodman KJ, Correa P, Tengan&aacute; Aux HJ, et al. Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol 1996; 144:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/45\">",
"      Thomas JE, Gibson GR, Darboe MK, et al. Isolation of Helicobacter pylori from human faeces. Lancet 1992; 340:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/46\">",
"      Malaty HM, Graham DY, Klein PD, et al. Transmission of Helicobacter pylori infection. Studies in families of healthy individuals. Scand J Gastroenterol 1991; 26:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/47\">",
"      Goodman KJ, Correa P. Transmission of Helicobacter pylori among siblings. Lancet 2000; 355:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/48\">",
"      Bamford KB, Bickley J, Collins JS, et al. Helicobacter pylori: comparison of DNA fingerprints provides evidence for intrafamilial infection. Gut 1993; 34:1348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/49\">",
"      Vincent P, Gottrand F, Pernes P, et al. High prevalence of Helicobacter pylori infection in cohabiting children. Epidemiology of a cluster, with special emphasis on molecular typing. Gut 1994; 35:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/50\">",
"      Schwarz S, Morelli G, Kusecek B, et al. Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog 2008; 4:e1000180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/51\">",
"      Hardo PG, Tugnait A, Hassan F, et al. Helicobacter pylori infection and dental care. Gut 1995; 37:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/52\">",
"      Kignel S, de Almeida Pina F, Andr&eacute; EA, et al. Occurrence of Helicobacter pylori in dental plaque and saliva of dyspeptic patients. Oral Dis 2005; 11:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/53\">",
"      Malaty HM, Evans DJ Jr, Abramovitch K, et al. Helicobacter pylori infection in dental workers: a seroepidemiology study. Am J Gastroenterol 1992; 87:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/54\">",
"      Axon AT. Review article: is Helicobacter pylori transmitted by the gastro-oral route? Aliment Pharmacol Ther 1995; 9:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/55\">",
"      Tytgat GN. Endoscopic transmission of Helicobacter pylori. Aliment Pharmacol Ther 1995; 9 Suppl 2:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/56\">",
"      Borody TJ, Andrews P, Mancuso N, et al. Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer. Am J Gastroenterol 1994; 89:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/57\">",
"      Archimandritis A, Balatsos V, Delis V, et al. \"Reappearance\" of Helicobacter pylori after eradication: implications on duodenal ulcer recurrence: a prospective 6 year study. J Clin Gastroenterol 1999; 28:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/58\">",
"      Mitchell HM, Hu P, Chi Y, et al. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 1998; 114:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43271/abstract/59\">",
"      Rowland M, Kumar D, Daly L, et al. Low rates of Helicobacter pylori reinfection in children. Gastroenterology 1999; 117:336.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-00FF42CD0A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43271=[""].join("\n");
var outline_f42_16_43271=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H100820650\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACTERIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Microbiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Gastric adaptation of H. pylori",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Possible hereditary susceptibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      H. pylori transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Reinfection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100820650\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/16\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/16|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/44/15043\" title=\"picture 1\">",
"      H pylori photomicrograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/15/30964\" title=\"picture 2A\">",
"      H pylori on crypt cells Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/20/42305\" title=\"picture 2B\">",
"      Adherence of Helicobacter pylori",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37817?source=related_link\">",
"      Indications and diagnostic tests for Helicobacter pylori infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/44/4809?source=related_link\">",
"      Pathophysiology of and immune response to Helicobacter pylori infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/31/19954?source=related_link\">",
"      Patient information: H. pylori infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/58/14242?source=related_link\">",
"      Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/38/618?source=related_link\">",
"      Risk factors for gastric cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_16_43272="Hereditary sensory and autonomic neuropathies";
var content_f42_16_43272=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hereditary sensory and autonomic neuropathies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/16/43272/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43272/contributors\">",
"     Robert P Cruse, DO",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/16/43272/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43272/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43272/contributors\">",
"     Helen V Firth, DM, FRCP, DCH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43272/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/16/43272/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43272/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/16/43272/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hereditary peripheral neuropathies have been classified based upon clinical characteristics, mode of inheritance, electrophysiologic features, metabolic defect, and specific genetic markers. The Dyck classification developed in the 1970s helped to define specific types based upon clinical and electrophysiologic features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/1\">",
"     1",
"    </a>",
"    ]. Many of the primary hereditary neuropathies were divided into motor-sensory and sensory&ndash;autonomic neuropathies.",
"   </p>",
"   <p>",
"    The primary hereditary sensory and autonomic neuropathies are reviewed here. The primary hereditary motor sensory neuropathies and the disorders affecting both the central and peripheral nervous systems are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/24/21895?source=see_link\">",
"     \"Overview of hereditary neuropathies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/59/35770?source=see_link\">",
"     \"Hereditary primary motor sensory neuropathies, including Charcot-Marie-Tooth disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/602?source=see_link\">",
"     \"Hereditary neuropathies associated with generalized disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84506193\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary sensory and autonomic neuropathies (HSANs) occur much less frequently than do the primary hereditary motor sensory neuropathies (HMSNs). The major feature of the HSANs is loss of large myelinated and unmyelinated fibers. They have been categorized into types one through five, although some children do not fit well into this classification (",
"    <a class=\"graphic graphic_table graphicRef67377 \" href=\"mobipreview.htm?36/19/37180\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Our understanding of the basic genetic abnormalities in these diseases is substantially less than that of the hereditary motor sensory neuropathies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HSAN1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary sensory and autonomic neuropathy type I (also known as hereditary sensory neuropathy type I and hereditary sensory radicular neuropathy) is the most common form of HSAN. It is characterized by progressive degeneration of dorsal root ganglion and motor neurons, leading to distal sensory loss and later distal muscle wasting and weakness and variable neural deafness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;HSAN1 is genetically heterogeneous. Most cases show autosomal dominant inheritance. At least four genes have been implicated in the disorder, but most of the genetic loci are unknown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HSAN1A is associated with several missense mutations in the SPTLC1 gene on chromosome 9q22.31 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/6-8\">",
"       6-8",
"      </a>",
"      ]. The gene encodes for serine palmitoyltransferase, long-chain base subunit-1, which is involved in the synthesis of sphingolipids. Mutations in this gene are associated with the accumulation of neurotoxic sphingolipid metabolites [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      HSAN1C is caused by missense mutations in the SPTLC2 gene on chromosome 14q24 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      HSN1D is caused by mutations in the ATL1 gene on chromosome 14q [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/11\">",
"       11",
"      </a>",
"      ]. The same gene is implicated as the cause of early-onset hereditary spastic paraplegia 3A [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      HSN1E is caused by mutations in the DNMT1 gene on chromosome 19p13.2 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/13\">",
"       13",
"      </a>",
"      ]. Onset occurs early in adulthood, and is characterized by progressive dementia and hearing loss in addition to distal sensory loss.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptom onset is usually during early adulthood, but ranges from early childhood until late adulthood. The core clinical features of HSAN1 are prominent sensory loss and a variable involvement of autonomic and motor systems. Sharp, brief leg pain typically is the initial symptom, followed by the development of foot ulcers caused by reduced sensation in the legs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/14\">",
"     14",
"    </a>",
"    ]. Complete sensation is lost with time, with the exception of facial sensation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/15\">",
"     15",
"    </a>",
"    ]. Involvement of the thinly myelinated A-delta and unmyelinated C-nerve fibers results in abnormal quantitative psychophysical testing to warm, cold and pain sensation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/1\">",
"     1",
"    </a>",
"    ]. Motor findings, including pes cavus, peroneal muscle atrophy, and loss of reflexes, may be present, and bone necrosis and spontaneous distal amputation can occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a detailed characterization of six families with a SPTLC1 mutation and a single patient with a sporadic SPTLC1 mutation, the following observations were noted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mean age of onset was 29 years, but ranged from age 12 to 70. One individual at age 89 was unaffected. There was a statistically nonsignificant tendency for females compared with males to have a later mean age of onset (39 versus 25 years); females also tended to have less severe disease. There was considerable heterogeneity both within and between families regarding the clinical and electrophysiologic findings.",
"     </li>",
"     <li>",
"      The most frequent presenting feature was decreased sensation in the feet. Limb pain, painless blisters and foot ulcers were also common, as was severe shooting or burning limb pain.",
"     </li>",
"     <li>",
"      Sensory involvement was typically dissociated, with pain and temperature affected first and most severely, and light touch affected to a lesser degree. Vibration and joint position sense were affected later and much less than superficial sensation.",
"     </li>",
"     <li>",
"      Motor signs were more frequent than expected from the earlier descriptions of HSAN1. Severe and often early motor signs were seen in most of the affected family members. The proximal and distal weakness and wasting was the most prominent feature of the disease in some patients, leading in some to a misdiagnosis of Charcot-Marie-Tooth disease. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/59/35770?source=see_link\">",
"       \"Hereditary primary motor sensory neuropathies, including Charcot-Marie-Tooth disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nerve conduction studies most frequently showed an axonal motor and sensory peripheral neuropathy; sensory potentials were usually absent in the lower limbs but were often present and in some cases normal in the upper limbs. Motor conduction showed great variability, with velocities ranging from normal (&ge;50",
"      <span class=\"nowrap\">",
"       m/s)",
"      </span>",
"      through intermediate slowing (35 to 50",
"      <span class=\"nowrap\">",
"       m/s)",
"      </span>",
"      to unequivocal slowing in the demyelinating range (&le;35",
"      <span class=\"nowrap\">",
"       m/s).",
"      </span>",
"      Conduction slowing, conduction block and motor dispersion (all suggestive of demyelination) were seen in several subjects.",
"     </li>",
"     <li>",
"      Needle electromyography of distal limb muscles showed moderate to severe chronic denervation.",
"     </li>",
"     <li>",
"      Sural nerve biopsy and postmortem examination showed significant loss of myelinated axons, but there was scant evidence of demyelination. The dorsal spinal roots were mildly fibrotic while ventral roots were relatively well preserved.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To summarize, the electrophysiologic studies showed a predominately axonal and sensory peripheral neuropathy, but a significant motor neuropathy was also present in most patients, and a minority had conduction studies suggestive of demyelination. Given the lack of significant demyelination on biopsy and postmortem samples, the authors speculated that abnormal axonal function and altered excitability rather than a defect of myelin itself may have been responsible for the motor slowing seen in these patients.",
"   </p>",
"   <p>",
"    Thus, the diagnosis of HSAN1 secondary to SPTLC1 mutations should be considered in patients with a motor and sensory neuropathy, even in the presence of demyelinating features, particularly if there is marked sensory involvement and a family history [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H535107360\">",
"    <span class=\"h2\">",
"     Management of HSAN1",
"    </span>",
"    &nbsp;&mdash;&nbsp;No specific treatment exists for HSAN1. Management requires meticulous care of the distal limbs, which includes proper fit of shoes, prevention and treatment of callus formation, cleaning and protection of wounds, and avoidance of trauma to the hands and feet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/17\">",
"     17",
"    </a>",
"    ]. Chronic ulcerations and infections can lead to osteomyelitis and the need for surgical amputation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/18\">",
"     18",
"    </a>",
"    ]. Ankle-foot orthotics are used for foot drop, and arthrodesis for Charcot arthropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25769873\">",
"    <span class=\"h2\">",
"     Experimental therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hypothesis that HSAN1 is caused by the accumulation of neurotoxic sphingolipid metabolites suggests that interventions aimed at reducing the level of toxic metabolites may be beneficial. The SPTLC1 mutations that cause HSAN1 are associated with reduced activity of the enzyme serine palmitoyltransferase, which catalyzes the condensation of L-serine and palmitoyl-CoA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In addition, SPTLC1 mutations result in reduced substrate specificity such that L-alanine and L-glycine are also condensed with palmitoyl-CoA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/9,19\">",
"     9,19",
"    </a>",
"    ], theoretically leading to formation of neurotoxic deoxysphingolipids.",
"   </p>",
"   <p>",
"    One proposed intervention involves dietary supplementation with oral L-serine. In a mouse model of HSAN1, SPTLC1 mutant mice placed on an L-serine enriched dieted demonstrated reduced deoxysphingolipid levels and improved performance on measures of motor and sensory neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/20\">",
"     20",
"    </a>",
"    ]. In addition, 14 patients with HSAN1 who received L-serine supplementation for 10 weeks showed reduced deoxysphingolipid levels. The study did not evaluate for any improvement in neurologic symptoms. Further study is needed to determine whether L-serine therapy is clinically safe and effective as a treatment for HSAN1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HSAN2",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms in hereditary sensory and autonomic neuropathy type 2 (HSAN2) are caused also by loss of pain, temperature, pressure and touch sensation with large and small fiber sensory involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/1,22\">",
"     1,22",
"    </a>",
"    ]. Recurrent infections of the digits and fractures occur in early childhood, and mutilation of the fingers and toes occurs as the disease progresses. A stable, nonprogressive congenital form also has been recognized [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sensory nerve action potentials are unobtainable with NCS, while motor conduction velocity is only mildly slowed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/24\">",
"     24",
"    </a>",
"    ]. Sural nerve biopsy shows a marked decrease or absence of large and small myelinated fibers but only slight reduction of unmyelinated fibers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/22,25,26\">",
"     22,25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;HSAN2 is transmitted as an autosomal recessive trait [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/22\">",
"     22",
"    </a>",
"    ]. At least three subtypes with different genetic origins have been described.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HSAN2A is caused by mutations in HSN2 gene, which is specific to the nervous system and located within exon 8 of the WNK1 gene on chromosome 12p13.33 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/27,28\">",
"       27,28",
"      </a>",
"      ]. This complex is referred to as the",
"      <span class=\"nowrap\">",
"       WNK1/HSN2",
"      </span>",
"      isoform. The apparently higher prevalence of HSAN2 in French Canadians may be due to the presence of two distinct founder mutations in the HSN2 gene [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      HSAN2B is caused by loss-of-function mutations in the FAM134B gene on chromosome 5p15.1 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/30\">",
"       30",
"      </a>",
"      ]. The phenotype of HSAN2B is similar to the progressive form of HSAN2A.",
"     </li>",
"     <li>",
"      HASN2C is caused by mutations in the KIF1A gene on chromosome 2q37.3 that encodes for a kinesin family protein involved in axonal transport of synaptic vesicles [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/31\">",
"       31",
"      </a>",
"      ]. The protein also interacts with the domain encoded by the HSN2 exon of the neuron-specific",
"      <span class=\"nowrap\">",
"       WNK1/HSN2",
"      </span>",
"      isoform. A mutation in the KIF1A gene is implicated as the cause of hereditary spastic paraplegia 30 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     HSAN3 (FAMILIAL DYSAUTONOMIA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary sensory and autonomic neuropathy type 3 (HSAN3) is more commonly known as familial dysautonomia or Riley-Day syndrome. This disorder is a progressive sensorimotor neuropathy, but sympathetic autonomic dysfunction is responsible for most clinical manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/33-35\">",
"     33-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Episodes of dysautonomic crises occur in many patients, characterized by nausea and vomiting, and by symptoms of sympathetic storm with irritability, tachycardia, hypertension, facial flushing, bronchorrhea, and diminished oral coordination resulting in swallowing and speech dysfunction. These crises can be triggered by physical or emotional stress.",
"     </li>",
"     <li>",
"      Additional autonomic symptoms include orthostatic hypotension, excessive salivation, gastrointestinal motility dysfunction, bladder dysfunction, decreased or absent tearing, pupil dilation, hypohidrosis and episodic hyperhidrosis (leading to defective temperature dysregulation), and blotchy skin.",
"     </li>",
"     <li>",
"      Glomerulosclerosis and chronic kidney disease may develop, unrelated to autonomic dysfunction.",
"     </li>",
"     <li>",
"      Neuropathic symptoms include loss of reflexes, hypotonia, and decreased perception of pain and temperature.",
"     </li>",
"     <li>",
"      Additional clinical features include small stature, kyphoscoliosis, a smooth tongue that lacks fungiform papillae, recurrent aspiration or vomiting, multiple sites of skin trauma, dysarthria, mental deficiencies, and emotional lability.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The respiratory, cardiovascular, and cerebrovascular responses to hypoxia are markedly diminished, but responses to hypercarbia remain intact [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Motor conduction velocity may be normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/37,38\">",
"     37,38",
"    </a>",
"    ] or reduced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Compound motor action potential amplitudes may also be reduced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/39\">",
"     39",
"    </a>",
"    ]. Sensory nerve action potentials are reduced or absent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The disease affects central as well as peripheral myelin. With aging, dorsal column abnormalities are found on quantitative testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/41\">",
"     41",
"    </a>",
"    ]. Sural nerve biopsy demonstrates severe loss of both myelinated and unmyelinated fibers smaller than 12 microns in diameter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/42\">",
"     42",
"    </a>",
"    ]. Histologic examination of sensory dorsal root ganglion shows a 50 percent reduction of neurons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/40\">",
"     40",
"    </a>",
"    ]. Both preganglionic and postganglionic sympathetic atrophy occur with preservation of parasympathetic ganglia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data from a retrospective study suggests that patients with familial dysautonomia have an increased incidence of neoplasia compared with the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Familial dysautonomia (HSAN3) is transmitted as an autosomal recessive trait and is essentially limited to children of Ashkenazi Jewish decent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/45\">",
"     45",
"    </a>",
"    ]. The carrier frequency is 1 in 30, and the incidence is approximately 1 in 3700 live births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/46\">",
"     46",
"    </a>",
"    ]. &nbsp;Only a few non-Jewish children have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/47-49\">",
"     47-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The causative gene is located on chromosome 9q31 and encodes for a truncated form of I kappa B kinase complex-associated protein (IKBKAP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. How this leads to the clinical manifestations of HSAN3 is not clear, but tissue-specific expression of the defective IKBKAP gene may be involved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic evaluation is sensitive and specific for the diagnosis of HSAN3. No other specific diagnostic test exists, although the following tests are suggestive:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intradermal histamine may produce a wheal but no flare or pain at the injection site. Histamine should be used at a 1:1000 dilution in adolescents, while a 1:10,000 dilution should be used in infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Urine excretion of vanillylmandelic acid excretion may be diminished, and excretion of homovanillic acid increased.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=see_link\">",
"       Methacholine",
"      </a>",
"      (2.5 percent) administration into the conjunctival sac produces no response in normal children, but induces pupillary constriction in children with familial dysautonomia.",
"     </li>",
"     <li>",
"      Blood pressure responses are exaggerated following intravenous norepinephrine, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=see_link\">",
"       methacholine",
"      </a>",
"      infusion generates an increased hypotensive response.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;No specific treatment exists for familial dysautonomia (HSAN3). Supportive care and symptomatic therapies are the mainstay of management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/45,53\">",
"     45,53",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vomiting and dysautonomic crisis may require intravenous fluids to prevent dehydration.",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/34/32296?source=see_link\">",
"       Diazepam",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/14/13545?source=see_link\">",
"       clonidine",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/31/16887?source=see_link\">",
"       pregabalin",
"      </a>",
"      may be helpful to control symptoms. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Dysautonomic crisis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Nutrition, airway protection, and avoidance of aspiration are important, particularly during infancy.",
"     </li>",
"     <li>",
"      Gastroesophageal reflux management includes upright positioning during feeding, prokinetic agents (eg,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?15/58/16291?source=see_link\">",
"       bethanechol",
"      </a>",
"      ), H2 antagonists, and gastrostomy with or with fundoplication.",
"     </li>",
"     <li>",
"      For patients with chronic lung disease from recurrent aspiration pneumonia, daily chest physiotherapy (ie, nebulizers, bronchodilators, postural drainage) is suggested. High frequency chest wall oscillation was beneficial in one report [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Orthostatic hypotension can be treated with elastic stockings, leg exercises, and physical maneuvers such as squatting and bending forward [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/55\">",
"       55",
"      </a>",
"      ].",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?43/32/44549?source=see_link\">",
"       Fludrocortisone",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/35/2613?source=see_link\">",
"       midodrine",
"      </a>",
"      may help orthostatic symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/56,57\">",
"       56,57",
"      </a>",
"      ]. Observational data suggest these agents prolong survival in patients with familial dysautonomia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/57\">",
"       57",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5161?source=see_link\">",
"       \"Treatment of orthostatic and postprandial hypotension\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with bradyarrhythmia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      syncope, a pacemaker may be protective [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Corneal scarring is a risk due to decreased corneal sensation and diminished tearing. Artificial tear solutions that contain",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/28/29123?source=see_link\">",
"       methylcellulose",
"      </a>",
"      can be given three to six times daily. Other measures include maintenance of normal hydration, moisture chamber spectacle attachments, and soft contact lenses. Tarsorrhaphy is an option if conservative measures fail.",
"     </li>",
"     <li>",
"      A yearly spine examination is suggested to evaluate for kyphoscoliosis; some patients may benefit from spinal fusion.",
"     </li>",
"     <li>",
"      Patients are at risk for decubitus ulcers due to decreased pain sensitivity. Awareness of pressure points is needed when fitting orthopedic devices.",
"     </li>",
"     <li>",
"      Exercise may be helpful to correct or prevent contractures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Dysautonomic crisis",
"    </span>",
"    &nbsp;&mdash;&nbsp;To control vomiting and dysautonomic crisis, some experts treat with intravenous or rectal",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/34/32296?source=see_link\">",
"     diazepam",
"    </a>",
"    (0.2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every three hours) or oral",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/14/13545?source=see_link\">",
"     clonidine",
"    </a>",
"    , starting at 0.005 to 0.01",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily in three or four divided doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/53\">",
"     53",
"    </a>",
"    ]. Clonidine may be increased gradually up to 0.025",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in four divided doses, with a maximum total dose of 0.9",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"   </p>",
"   <p>",
"    In",
"    a case series, treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/31/16887?source=see_link\">",
"     pregabalin",
"    </a>",
"    was associated with improvement in nausea and symptoms of dysautonomic crisis in 13 of 15 patients, most of whom were maintained on their prestudy regimen of a benzodiazepine",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/14/13545?source=see_link\">",
"     clonidine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/59\">",
"     59",
"    </a>",
"    ]. Pregabalin was started at 25 to 50 mg twice daily and gradually titrated over one month to benefit or a maximum total daily dose of 6",
"    <span class=\"nowrap\">",
"     mg/kg.",
"    </span>",
"   </p>",
"   <p>",
"    As noted earlier, intravenous fluids are used to prevent dehydration with vomiting crises.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Prenatal screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to prenatal screening in Ashkenazi Jews are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/24/12681?source=see_link\">",
"     \"Prenatal screening for genetic disease in the Ashkenazi Jewish population\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Intrauterine diagnosis of familial dysautonomia (HSAN3) can be made with up to 98 percent accuracy using linked genetic markers in affected families [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/60-62\">",
"     60-62",
"    </a>",
"    ], although higher accuracy would be anticipated by testing for the known familial mutations. Since the advent of prenatal screening for the gene linked to familial dysautonomia in 2001, the incidence of newborns with the disease has markedly declined in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     HSAN4",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary sensory and autonomic neuropathy type 4 (HSAN4), also called congenital insensitivity to pain with anhidrosis (CIPA), is an autosomal recessive disorder. Symptoms begin early in infancy and prominent features include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/64\">",
"     64",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Profound loss of pain sensitivity, leading to injuries, self-mutilation, and osteomyelitis. Loss of oral sensation leads to mutilation of the face and mouth.",
"     </li>",
"     <li>",
"      Defects in thermoregulation and anhidrosis, leading to episodic hyperthermia that can be associated with seizures.",
"     </li>",
"     <li>",
"      Mild to moderate mental retardation; in addition, microcephaly often is present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Tearing is preserved, and fungiform papillae are present on the tongue; both serve to differentiate HSAN4 from the Riley-Day syndrome (HSAN3). Up to 20 percent of patients die from hyperpyrexia by three years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neuropathologic findings include a marked reduction in sural nerve size and a severe reduction in unmyelinated and small myelinated fibers in peripheral nerves.",
"   </p>",
"   <p>",
"    HSAN4 has been linked to mutations within the tyrosinase-kinase domain of the NTRK1 gene on chromosome 1q23.1, which encodes one of the receptors for the nerve growth factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/65\">",
"     65",
"    </a>",
"    ]. These mutations cause inactivation of the receptor, producing a loss of function effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/66\">",
"     66",
"    </a>",
"    ]. Nerve growth factor normally induces neurite outgrowth and promotes survival of embryonic sensory and sympathetic neurons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/67\">",
"     67",
"    </a>",
"    ]. It is likely that another gene also is involved. In a series of nine unrelated consanguineous families, the disease was not linked to the NTRK1 gene in one family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     HSAN5",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hereditary sensory and autonomic neuropathy type 5 (HSAN5) have loss of pain and temperature sensation, but other sensation is preserved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/69\">",
"     69",
"    </a>",
"    ]. Muscle strength, reflexes, and nerve conduction studies are normal. However, one report of a single consanguineous family noted additional manifestations including mild mental retardation, anhidrosis, and chronic immunodeficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sural nerve biopsy shows absence of the small myelinated fibers, with preservation of the large fibers. Inheritance is autosomal recessive. HSAN5 appears to be caused by mutations in the nerve growth factor beta (NGFB) gene on chromosome 1p13.2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/70,71\">",
"     70,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     UNCLASSIFIED",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several cases of hereditary sensory neuropathy in children that do not fit into the current classification have been reported. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A hereditary sensory and autonomic neuropathy with dysautonomia, distal contractures, severe psychomotor retardation, and early death, caused by a mutation in the dystonin (DST) gene [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/72\">",
"       72",
"      </a>",
"      ]. The investigators have proposed that this condition be designated HSAN6.",
"     </li>",
"     <li>",
"      Spastic paraplegia with ulcerations of the hands and feet associated with CCT5 gene mutations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/73,74\">",
"       73,74",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Congenital sensory neuropathy with skeletal dysplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/75\">",
"       75",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hereditary sensory neuropathy with neurotrophic keratitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/76\">",
"       76",
"      </a>",
"      ], which may be a variant of HSAN5",
"     </li>",
"     <li>",
"      Congenital sensory polyneuropathy with growth hormone deficiency [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/77\">",
"       77",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Sensory neuropathy with ichthyosis and anterior chamber syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/78\">",
"       78",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Deafness, sensory neuropathy, and ovarian dysgenesis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/79\">",
"       79",
"      </a>",
"      ], which may be a variant of gonadal dysgenesis, XX type, with deafness",
"     </li>",
"     <li>",
"      Navajo familial neurogenic arthropathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43272/abstract/80\">",
"       80",
"      </a>",
"      ], which may be a variant of Navajo neurohepatopathy related to mutations of the MPV17 gene",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84506154\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The major feature of the hereditary sensory and autonomic neuropathies (HSANs) is loss of large myelinated and unmyelinated fibers. They have been categorized into five types (",
"      <a class=\"graphic graphic_table graphicRef67377 \" href=\"mobipreview.htm?36/19/37180\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H84506193\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hereditary sensory and autonomic neuropathy type I (HSAN1) is the most common form of HSAN. It is characterized by progressive degeneration of dorsal root ganglion and motor neurons, leading to distal sensory loss and later to distal muscle wasting and weakness. The core clinical features of HSAN1 are prominent sensory loss and a variable involvement of autonomic and motor systems. Some affected families have hearing loss and dementia. Inheritance is autosomal dominant. At least four genetic subtypes are known. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'HSAN1'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hereditary sensory and autonomic neuropathy type 2 (HSAN2) are caused also by loss of pain, temperature, pressure and touch sensation with large and small fiber sensory involvement. Inheritance is autosomal recessive, and at least three genetic subtypes are described. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'HSAN2'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hereditary sensory and autonomic neuropathy type 3 (HSAN3) is more commonly known as familial dysautonomia. This disorder is a progressive sensorimotor neuropathy, but sympathetic autonomic dysfunction is responsible for most clinical manifestations. It is transmitted as an autosomal recessive trait and is essentially limited to children of Ashkenazi Jewish decent. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'HSAN3 (Familial dysautonomia)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hereditary sensory and autonomic neuropathy type 4 (HSAN4), also called congenital insensitivity to pain with anhidrosis (CIPA), is an autosomal recessive disorder. Some cases are caused by mutations in the NTRK1 gene. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'HSAN4'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hereditary sensory and autonomic neuropathy type 5 (HSAN5) is an autosomal recessive disorder characterized by loss of pain and temperature sensation. The cause is mutations in the NGFB gene. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'HSAN5'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some cases of hereditary sensory neuropathy in children do not fit into the current classification. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Unclassified'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Dyck, PJ. Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Peripheral neuropathy, vol 2, Dyck, PJ, Thomas, PK, Griffin, JW, Low, PA, (Eds), WB Saunders, Philadelphia, 1993; p.1065.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/2\">",
"      Thomas PK. Hereditary sensory neuropathies. Brain Pathol 1993; 3:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/3\">",
"      Fitzpatrick DB, Hooper RE, Seife B. Hereditary deafness and sensory radicular neuropathy. Arch Otolaryngol 1976; 102:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/4\">",
"      Houlden H, King R, Blake J, et al. Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I). Brain 2006; 129:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/5\">",
"      Rotthier A, Baets J, De Vriendt E, et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain 2009; 132:2699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/6\">",
"      Dawkins JL, Hulme DJ, Brahmbhatt SB, et al. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 2001; 27:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/7\">",
"      Bejaoui K, Wu C, Scheffler MD, et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet 2001; 27:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/8\">",
"      Klein CJ, Wu Y, Kruckeberg KE, et al. SPTLC1 and RAB7 mutation analysis in dominantly inherited and idiopathic sensory neuropathies. J Neurol Neurosurg Psychiatry 2005; 76:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/9\">",
"      Penno A, Reilly MM, Houlden H, et al. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem 2010; 285:11178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/10\">",
"      Rotthier A, Auer-Grumbach M, Janssens K, et al. Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am J Hum Genet 2010; 87:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/11\">",
"      Guelly C, Zhu PP, Leonardis L, et al. Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet 2011; 88:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/12\">",
"      Namekawa M, Ribai P, Nelson I, et al. SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology 2006; 66:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/13\">",
"      Klein CJ, Botuyan MV, Wu Y, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011; 43:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/14\">",
"      Berginer V, Baruchin A, Ben-Yakar Y, Mahler D. Plantar ulcers in hereditary sensory neuropathy. A plea for conservative treatment. Int J Dermatol 1984; 23:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/15\">",
"      Nance PW, Kirby RL. Rehabilitation of an adult with disabilities due to congenital sensory neuropathy. Arch Phys Med Rehabil 1985; 66:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/16\">",
"      Teot L, Arnal F, Humeau C, et al. Ultrastructural aspects of nerves, bones, and vessels in hereditary sensory neuropathy. J Orthop Res 1985; 3:226.",
"     </a>",
"    </li>",
"    <li>",
"     Nicholson GA. Hereditary sensory neuropathy type IA. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK1390/ (Accessed on December 20, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/18\">",
"      Gwathmey FW, House JH. Clinical manifestations of congenital insensitivity of the hand and classification of syndromes. J Hand Surg Am 1984; 9:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/19\">",
"      Gable K, Gupta SD, Han G, et al. A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity. J Biol Chem 2010; 285:22846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/20\">",
"      Garofalo K, Penno A, Schmidt BP, et al. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J Clin Invest 2011; 121:4735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/21\">",
"      Scherer SS. The debut of a rational treatment for an inherited neuropathy? J Clin Invest 2011; 121:4624.",
"     </a>",
"    </li>",
"    <li>",
"     Kurth I. Hereditary sensory and autonomic neuropathy type II. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK49247/ (Accessed on December 08, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/23\">",
"      Ferri&egrave;re G, Guzzetta F, Kulakowski S, Evrard P. Nonprogressive type II hereditary sensory autonomic neuropathy: a homogeneous clinicopathologic entity. J Child Neurol 1992; 7:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/24\">",
"      Ota M, Ellefson RD, Lambert EH, Dyck PJ. Hereditary sensory neuropathy, type II. Clinical, electrophysiologic, histologic, and biochemical studies of a Quebec kinship. Arch Neurol 1973; 29:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/25\">",
"      Nukada H, Pollock M, Haas LF. The clinical spectrum and morphology of type II hereditary sensory neuropathy. Brain 1982; 105 (Pt 4):647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/26\">",
"      Berciano J, Combarros O, Figols J, et al. Hereditary motor and sensory neuropathy type II. Clinicopathological study of a family. Brain 1986; 109 ( Pt 5):897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/27\">",
"      Lafreniere RG, MacDonald ML, Dube MP, et al. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet 2004; 74:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/28\">",
"      Shekarabi M, Girard N, Rivi&egrave;re JB, et al. Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II. J Clin Invest 2008; 118:2496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/29\">",
"      Roddier K, Thomas T, Marleau G, et al. Two mutations in the HSN2 gene explain the high prevalence of HSAN2 in French Canadians. Neurology 2005; 64:1762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/30\">",
"      Kurth I, Pamminger T, Hennings JC, et al. Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat Genet 2009; 41:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/31\">",
"      Rivi&egrave;re JB, Ramalingam S, Lavastre V, et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet 2011; 89:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/32\">",
"      Erlich Y, Edvardson S, Hodges E, et al. Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. Genome Res 2011; 21:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/33\">",
"      RILEY CM, DAY RL. Central autonomic dysfunction with defective lacrimation; report of five cases. Pediatrics 1949; 3:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/34\">",
"      Axelrod FB. Familial dysautonomia. Muscle Nerve 2004; 29:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/35\">",
"      Elkayam L, Matalon A, Tseng CH, Axelrod F. Prevalence and severity of renal disease in familial dysautonomia. Am J Kidney Dis 2006; 48:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/36\">",
"      Bernardi L, Hilz M, Stemper B, et al. Respiratory and cerebrovascular responses to hypoxia and hypercapnia in familial dysautonomia. Am J Respir Crit Care Med 2003; 167:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/37\">",
"      Brown JC, Johns RJ. Nerve conduction in familial dysautonomia (Riley-Day syndrome). JAMA 1967; 201:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/38\">",
"      Nordborg C, Conradi N, Sourander P, Westerberg B. A new type of non-progressive sensory neuropathy in children with atypical dysautonomia. Acta Neuropathol 1981; 55:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/39\">",
"      Kuhlenb&auml;umer G, Young P, H&uuml;nermund G, et al. Clinical features and molecular genetics of hereditary peripheral neuropathies. J Neurol 2002; 249:1629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/40\">",
"      Aguayo AJ, Nair CP, Bray GM. Peripheral nerve abnormalities in the Riley-Day syndrome. Findings in a sural nerve biopsy. Arch Neurol 1971; 24:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/41\">",
"      Pearson J, Pytel BA. Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia. J Neurol Sci 1978; 39:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/42\">",
"      Jaradeh SS. Hereditary neuropathies. J Clin Neuromuscul Dis 2003; 5:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/43\">",
"      Pearson J, Pytel B. Quantitative studies of ciliary and sphenopalatine ganglia in familial dysautonomia. J Neurol Sci 1978; 39:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/44\">",
"      Gold-von Simson G, Romanos-Sirakis E, Maayan C, Axelrod FB. Neoplasia in familial dysautonomia: a 20-year review in a young patient population. J Pediatr 2009; 155:934.",
"     </a>",
"    </li>",
"    <li>",
"     Shohat M, Halpern GJ. Familial dysautonomia. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK1180/ (Accessed on December 08, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/46\">",
"      Maayan C, Kaplan E, Shachar S, et al. Incidence of familial dysautonomia in Israel 1977-1981. Clin Genet 1987; 32:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/47\">",
"      Klebanoff MA, Neff JM. Familial dysautonomia associated with recurrent osteomyelitis in a non-Jewish girl. J Pediatr 1980; 96:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/48\">",
"      Levine SL, Manniello RL, Farrell PM. Familial dysautonomia: unusual presentation in an infant of non-Jewish ancestry. J Pediatr 1977; 90:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/49\">",
"      Mehta K. Familial dysautonomia in a Hindu boy. Am J Dis Child 1978; 132:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/50\">",
"      Slaugenhaupt SA, Blumenfeld A, Gill SP, et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 2001; 68:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/51\">",
"      Anderson SL, Coli R, Daly IW, et al. Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet 2001; 68:753.",
"     </a>",
"    </li>",
"    <li>",
"     Nelson textbook of pediatrics, 15th ed, Behrman, RE, Kliegman, RM, Marvin, AM (Eds), W.B. Saunders, Philadelphia 1996. p.1760.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/53\">",
"      Axelrod FB. Familial dysautonomia: a review of the current pharmacological treatments. Expert Opin Pharmacother 2005; 6:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/54\">",
"      Giarraffa P, Berger KI, Chaikin AA, et al. Assessing efficacy of high-frequency chest wall oscillation in patients with familial dysautonomia. Chest 2005; 128:3377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/55\">",
"      Tutaj M, Marthol H, Berlin D, et al. Effect of physical countermaneuvers on orthostatic hypotension in familial dysautonomia. J Neurol 2006; 253:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/56\">",
"      Axelrod FB, Krey L, Glickstein JS, et al. Preliminary observations on the use of midodrine in treating orthostatic hypotension in familial dysautonomia. J Auton Nerv Syst 1995; 55:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/57\">",
"      Axelrod FB, Goldberg JD, Rolnitzky L, et al. Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression. Clin Auton Res 2005; 15:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/58\">",
"      Gold-von Simson G, Rutkowski M, Berlin D, Axelrod FB. Pacemakers in patients with familial dysautonomia--a review of experience with 20 patients. Clin Auton Res 2005; 15:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/59\">",
"      Axelrod FB, Berlin D. Pregabalin: a new approach to treatment of the dysautonomic crisis. Pediatrics 2009; 124:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/60\">",
"      Eng CM, Slaugenhaupt SA, Blumenfeld A, et al. Prenatal diagnosis of familial dysautonomia by analysis of linked CA-repeat polymorphisms on chromosome 9q31-q33. Am J Med Genet 1995; 59:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/61\">",
"      Oddoux C, Reich E, Axelrod F, et al. Prenatal diagnostic testing for familial dysautonomia using linked genetic markers. Prenat Diagn 1995; 15:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/62\">",
"      Blumenfeld A, Slaugenhaupt SA, Liebert CB, et al. Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31. Am J Hum Genet 1999; 64:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/63\">",
"      Lerner BH. When diseases disappear--the case of familial dysautonomia. N Engl J Med 2009; 361:1622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/64\">",
"      Rosemberg S, Marie SK, Kliemann S. Congenital insensitivity to pain with anhidrosis (hereditary sensory and autonomic neuropathy type IV). Pediatr Neurol 1994; 11:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/65\">",
"      Indo Y, Tsuruta M, Hayashida Y, et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 1996; 13:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/66\">",
"      Greco A, Villa R, Fusetti L, et al. The Gly571Arg mutation, associated with the autonomic and sensory disorder congenital insensitivity to pain with anhidrosis, causes the inactivation of the NTRK1/nerve growth factor receptor. J Cell Physiol 2000; 182:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/67\">",
"      Indo Y, Mardy S, Tsuruta M, et al. Structure and organization of the human TRKA gene encoding a high affinity receptor for nerve growth factor. Jpn J Hum Genet 1997; 42:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/68\">",
"      Shatzky S, Moses S, Levy J, et al. Congenital insensitivity to pain with anhidrosis (CIPA) in Israeli-Bedouins: genetic heterogeneity, novel mutations in the TRKA/NGF receptor gene, clinical findings, and results of nerve conduction studies. Am J Med Genet 2000; 92:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/69\">",
"      Dyck PJ, Mellinger JF, Reagan TJ, et al. Not 'indifference to pain' but varieties of hereditary sensory and autonomic neuropathy. Brain 1983; 106 (Pt 2):373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/70\">",
"      Carvalho OP, Thornton GK, Hertecant J, et al. A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet 2011; 48:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/71\">",
"      Einarsdottir E, Carlsson A, Minde J, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet 2004; 13:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/72\">",
"      Edvardson S, Cinnamon Y, Jalas C, et al. Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol 2012; 71:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/73\">",
"      Cavanagh NP, Eames RA, Galvin RJ, et al. Hereditary sensory neuropathy with spastic paraplegia. Brain 1979; 102:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/74\">",
"      Bouhouche A, Benomar A, Bouslam N, et al. Autosomal recessive mutilating sensory neuropathy with spastic paraplegia maps to chromosome 5p15.31-14.1. Eur J Hum Genet 2006; 14:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/75\">",
"      Axelrod FB, Pearson J, Tepperberg J, Ackerman BD. Congenital sensory neuropathy with skeletal dysplasia. J Pediatr 1983; 102:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/76\">",
"      Donaghy M, Hakin RN, Bamford JM, et al. Hereditary sensory neuropathy with neurotrophic keratitis. Description of an autosomal recessive disorder with a selective reduction of small myelinated nerve fibres and a discussion of the classification of the hereditary sensory neuropathies. Brain 1987; 110 ( Pt 3):563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/77\">",
"      Liberfarb RM, Jackson AH, Eavey RD, Robb RM. Unique hereditary sensory and autonomic neuropathy with growth hormone deficiency. J Child Neurol 1993; 8:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/78\">",
"      Quinlivan R, Robb S, Hughes RA, et al. Congenital sensory neuropathy in association with ichthyosis and anterior chamber cleavage syndrome. Neuromuscul Disord 1993; 3:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/79\">",
"      Linssen WH, Van den Bent MJ, Brunner HG, Poels PJ. Deafness, sensory neuropathy, and ovarian dysgenesis: a new syndrome or a broader spectrum of Perrault syndrome? Am J Med Genet 1994; 51:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43272/abstract/80\">",
"      Johnsen SD, Johnson PC, Stein SR. Familial sensory autonomic neuropathy with arthropathy in Navajo children. Neurology 1993; 43:1120.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6227 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-199.231.185.123-2733C36ADC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43272=[""].join("\n");
var outline_f42_16_43272=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H84506154\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84506193\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HSAN1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H535107360\">",
"      Management of HSAN1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25769873\">",
"      Experimental therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HSAN2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      HSAN3 (FAMILIAL DYSAUTONOMIA)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Dysautonomic crisis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Prenatal screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      HSAN4",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      HSAN5",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      UNCLASSIFIED",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84506154\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6227\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6227|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/19/37180\" title=\"table 1\">",
"      Clinical features HSAN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/602?source=related_link\">",
"      Hereditary neuropathies associated with generalized disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/59/35770?source=related_link\">",
"      Hereditary primary motor sensory neuropathies, including Charcot-Marie-Tooth disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/24/21895?source=related_link\">",
"      Overview of hereditary neuropathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/24/12681?source=related_link\">",
"      Prenatal screening for genetic disease in the Ashkenazi Jewish population",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5161?source=related_link\">",
"      Treatment of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_16_43273="Reversible posterior leukoencephalopathy syndrome";
var content_f42_16_43273=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Reversible posterior leukoencephalopathy syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/16/43273/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43273/contributors\">",
"     Terry A Neill, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43273/contributors\">",
"     J Claude Hemphill, III, MD, MAS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/16/43273/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43273/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/16/43273/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/16/43273/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/16/43273/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reversible posterior leukoencephalopathy syndrome (RPLS) is a clinical radiographic syndrome of heterogeneous etiologies that are grouped together because of similar findings on neuroimaging studies. It is also often referred to as:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Posterior reversible encephalopathy syndrome (PRES)",
"     </li>",
"     <li>",
"      Reversible posterior cerebral edema syndrome",
"     </li>",
"     <li>",
"      Posterior leukoencephalopathy syndrome",
"     </li>",
"     <li>",
"      Hyperperfusion encephalopathy",
"     </li>",
"     <li>",
"      Brain capillary leak syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    None of these names is completely satisfactory; the syndrome is not always reversible, and it is often not confined to either the white matter or the posterior regions of the brain.",
"   </p>",
"   <p>",
"    Although described in various specific case reports for some time, it was first codified as a single named syndrome in a 1996 case series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1\">",
"     1",
"    </a>",
"    ]. This described a clinical syndrome of insidious onset of headache, confusion or decreased level of consciousness, visual changes, and seizures, which was associated with characteristic neuroimaging findings of posterior cerebral white matter edema.",
"   </p>",
"   <p>",
"    RPLS has been described in a number of medical conditions, with hypertensive encephalopathy, eclampsia, and the use of cytotoxic and immunosuppressant drugs being the most common. Prompt recognition and treatment is important in preventing the permanent damage that can occur in this otherwise typically reversible condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reversible posterior leukoencephalopathy syndrome (RPLS) is increasingly recognized and reported in case reports and case series; however, the incidence of RPLS is not known.",
"   </p>",
"   <p>",
"    Patients in all age groups appear susceptible; reported cases exist in patients as young as two years and as old as 90 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Case series suggest that RPLS is more common in women, even when patients with eclampsia are excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,6-8\">",
"     1,6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypertensive disorders, renal disease, and immunosuppressive therapies are risk factors for this disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of reversible posterior leukoencephalopathy syndrome (RPLS) remains unclear, but it appears to be related to disordered cerebral autoregulation and endothelial dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1\">",
"     1",
"    </a>",
"    ]. Because of the heterogeneous nature of this disorder, it may be that different mechanisms are etiologically important in different clinical situations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Autoregulatory failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal autoregulation maintains constant cerebral blood flow over a range of systemic blood pressure, by means of arteriolar constriction and dilatation (",
"    <a class=\"graphic graphic_figure graphicRef67583 \" href=\"mobipreview.htm?18/2/18477\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef57676 \" href=\"mobipreview.htm?33/13/34013\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. As the upper limit of cerebral autoregulation is exceeded, arterioles dilate and cerebral blood flow increases in a pressure-passive manner with rises in systemic blood pressure. The resulting brain hyperperfusion, particularly in arterial border zones, may lead to breakdown of the blood brain barrier allowing extravasation of fluid and blood products into the brain parenchyma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rate of blood pressure elevation is likely to be important. In chronic hypertension, adaptive vascular changes \"reset\" the range of autoregulation to higher systemic blood pressures (",
"    <a class=\"graphic graphic_figure graphicRef57676 \" href=\"mobipreview.htm?33/13/34013\">",
"     figure 2",
"    </a>",
"    ). As a result, patients with RPLS in the setting of longstanding hypertension may have markedly elevated blood pressures, while less severe elevations, even normal blood pressures, are associated with RPLS in other settings. Children appear particularly vulnerable to RPLS at lower blood pressures than adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,11\">",
"     2,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cerebral ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alternatively, in severe cases, it has been postulated that disordered cerebral autoregulation may lead to reactive focal vasoconstriction, thereby resulting in local hypoperfusion, cytotoxic edema, and cerebral infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/6,12,13\">",
"     6,12,13",
"    </a>",
"    ]. It is also possible that the cerebral infarctions, which uncommonly occur in RPLS, could result from compression of microcirculation from the mass effect of vasogenic edema. Some patients, but not all, have demonstrable vasoconstriction on radiologic imaging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/8,14\">",
"     8,14",
"    </a>",
"    ]. Also, radionuclide studies have demonstrated perfusion deficits in some patients with RPLS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Neuroimaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, ischemia is not believed to play the major pathophysiologic role in most patients with RPLS. Pathologic data, while quite limited, have not reported ischemia or infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/17\">",
"     17",
"    </a>",
"    ]; increased rather than decreased perfusion can also be seen on radionuclide imaging studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/18\">",
"     18",
"    </a>",
"    ], and many patients with RPLS do not have demonstrable vascular narrowing. Most persuasive in this regard is that most patients have complete reversibility of clinical and neuroradiographic findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Endothelial dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelial dysfunction has also been implicated in the pathophysiology of RPLS, especially in cases associated with preeclampsia or cytotoxic therapies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The latter may have direct toxicity on vascular endothelium, leading to capillary leakage, and blood-brain barrier disruption and axonal swelling, which may then trigger vasogenic edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,19\">",
"     1,19",
"    </a>",
"    ]. RPLS associated with these therapies may occur in normotensive individuals and with nontoxic levels of these drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In preeclampsia, markers of endothelial cell dysfunction (lactate dehydrogenase, abnormal red blood cell morphology) typically arise prior to the clinical syndrome and correlate better with the extent of cerebral edema than do blood pressure changes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. More specific markers of endothelial dysfunction that have also been found to be released in patients with preeclampsia include fibronectin, tissue plasminogen activator, thrombomodulin, endothelin-1, and, in particular, von Willebrand factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. Secretion of trophoblastic cytotoxic factors originating from a poorly perfused fetal unit may provide the initial stimulus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34777?source=see_link\">",
"     \"Pathogenesis of preeclampsia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Markers of endothelial cell dysfunction have also been reported in patients with RPLS in other clinical settings including chronic renal failure, lupus nephritis, and hemolytic uremic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"     2",
"    </a>",
"    ]. While cases of RPLS associated with thrombotic thrombocytopenic purpura usually occur with coexistent hypertension and renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/27\">",
"     27",
"    </a>",
"    ], one reported case in the absence of these complications suggests a primary role for endothelial injury in this setting as well [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some clinical settings, uremia, sepsis, hypomagnesemia, and other metabolic disturbances have been implicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/6,19\">",
"     6,19",
"    </a>",
"    ]. These factors may mediate their effect on the vascular endothelium or other sites of vasogenic control. Fluid overload may also contribute to cerebral edema in some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Anatomic distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of acute hypertension and endothelial damage results in hydrostatic edema, a specific form of vasogenic edema characterized by the forced leakage of serum through capillary walls and into the brain interstitium, which, if severe enough, will be radiographically evident. Unregulated vascular injury to blood-brain barrier endothelium leads to edema, protein extravasation, and fibrinoid necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/29\">",
"     29",
"    </a>",
"    ]. The cortex, structurally more tightly packed than the white matter, resists accumulation of edema, hence predilection of abnormalities to be seen in the white matter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The primary involvement of posterior brain regions is not well understood. One possibility involves the regional heterogeneity of the sympathetic innervation of the intracranial arterioles, which has been shown to protect the brain from marked increases in blood pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/31\">",
"     31",
"    </a>",
"    ]. A histochemical study revealed a greater concentration of adrenergic nerves around pial and intracerebral vessels in the anterior circulation than posteriorly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/32\">",
"     32",
"    </a>",
"    ]. This observation may explain why the hyperperfusion and edema is mainly seen in the posterior circulation in RPLS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ASSOCIATED CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A wide variety of medical conditions have been implicated as causes of reversible posterior leukoencephalopathy syndrome (RPLS) (",
"    <a class=\"graphic graphic_table graphicRef51758 \" href=\"mobipreview.htm?21/50/22316\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Comorbid medical conditions (ischemic bowel disease, sepsis, hyponatremia, fever, proteinuria) can exacerbate neurologic deterioration in patients and are therefore important to identify [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/6\">",
"     6",
"    </a>",
"    ]. Some conditions (eg, autoimmune disease) may be associated with RPLS either because of their secondary effects on blood pressure or because of medications used to treat them [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/33,35\">",
"     33,35",
"    </a>",
"    ]. The more common causes of RPLS will be reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hypertensive encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In acute, severe hypertension, RPLS results from acute elevation of blood pressure beyond the upper limits of cerebral autoregulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1\">",
"     1",
"    </a>",
"    ]. The neurologic syndrome in hypertensive encephalopathy is now believed to be caused by vasogenic edema from this breakthrough of autoregulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/18,36-38\">",
"     18,36-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rapidly developing, fluctuating, or intermittent hypertension carries a particular risk for hypertensive encephalopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients with untreated or undertreated chronic hypertension, renal failure, or preeclampsia-eclampsia are particular populations where this may be seen. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The percent elevation of blood pressure over baseline, as well as the severity of the hypertension, are important [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. RPLS may therefore occur in normotensive patients. Although RPLS is described in malignant hypertension alone, it appears to be more common in patients with comorbid conditions, such as systemic lupus erythematosus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/18,38,40,41\">",
"     18,38,40,41",
"    </a>",
"    ], cryoglobulinemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/42\">",
"     42",
"    </a>",
"    ], or hemolytic uremic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/38,43,44\">",
"     38,43,44",
"    </a>",
"    ], and in patients treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/45\">",
"     45",
"    </a>",
"    ] or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/19\">",
"     19",
"    </a>",
"    ]. The fact that renal failure appears to be particularly prevalent among hypertensive patients with RPLS suggests a role for either fluid overload, electrolyte disturbances, or uremia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Eclampsia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most investigators believe hypertensive encephalopathy and preeclampsia share similar mechanisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/15,47\">",
"     15,47",
"    </a>",
"    ]. In many patients, the syndrome occurs during the puerperium rather than during pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/48\">",
"     48",
"    </a>",
"    ]. Some suggest that RPLS (typical clinical syndrome and neuroimaging findings) could be considered an indicator of eclampsia, even when the other features of eclampsia (proteinuria, hypertension) are not present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/49\">",
"     49",
"    </a>",
"    ]. Blood pressures in patients with preeclampsia and eclampsia who develop RPLS are generally lower than in patients who develop RPLS in other settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34777?source=see_link\">",
"     \"Pathogenesis of preeclampsia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Immunosuppressive therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neurotoxic effects of these therapies are well known but still poorly understood. Toxic levels of medications are not required for the development of RPLS, and prior exposure to the drug does not appear to be protective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"     2",
"    </a>",
"    ]. Even after several months of exposure to the drug, patients with therapeutic levels can be symptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"     2",
"    </a>",
"    ]. Patients may be normotensive, but the blood pressure is usually elevated over baseline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,50\">",
"     1,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    is one of the more common cytotoxic therapies associated with the neurologic deficits of RPLS. After renal toxicity, neurotoxicity is the most serious side effect with cyclosporine, affecting 25 percent to 59 percent of transplant patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/51\">",
"     51",
"    </a>",
"    ]. Hypomagnesemia, hypocholesterolemia, the vasoactive agent endothelin, and hypertension have all been implicated in facilitating cyclosporine neurotoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/51\">",
"     51",
"    </a>",
"    ]. Cyclosporine may in turn exacerbate hypertension by inhibiting nitric oxide production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/52\">",
"     52",
"    </a>",
"    ]. The mechanism of cyclosporine cellular injury is thought to be mediated through mitochondrial dysfunction; this is supported by the similarity of the symptoms of cyclosporine neurotoxicity and mitochondrial encephalopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=see_link\">",
"     \"Pharmacology and side effects of cyclosporine and tacrolimus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These concepts are illustrated in a study that assessed the factors responsible for the neurotoxic effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/45\">",
"     45",
"    </a>",
"    ]. Sixteen patients with neurologic injury attributed to cyclosporine therapy were evaluated by neuroimaging as well as various clinical and laboratory data. Systemic hypertension was the only major factor associated with the neurotoxic effects of cyclosporine, although microangiopathic hemolytic anemia, thrombocytopenia, and hypoalbuminemia were common. Clinical and radiologic findings resembled those of hypertensive encephalopathy. Elevated serum cyclosporine levels were not related to the onset of neurologic symptoms.",
"   </p>",
"   <p>",
"    While RPLS with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    use is most often reported, RPLS has been associated with other agents, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    , and interferon therapies, and agents that target angiogenesis such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    , a monoclonal antibody directed against vascular endothelial growth factor (VEGF) and small molecule tyrosine kinase inhibitors that target the VEGF receptor (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/2/1064?source=see_link\">",
"     pazopanib",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/45/9944?source=see_link\">",
"     sorafenib",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/10/44200?source=see_link\">",
"     sunitinib",
"    </a>",
"    ) (",
"    <a class=\"graphic graphic_table graphicRef51758 \" href=\"mobipreview.htm?21/50/22316\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,19,54-60\">",
"     1,19,54-60",
"    </a>",
"    ]. The mechanisms are thought to be similar. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43882?source=see_link&amp;anchor=H1651228679#H1651228679\">",
"     \"Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects\", section on 'Reversible posterior leukoencephalopathy and brain capillary leak syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical syndrome of reversible posterior leukoencephalopathy syndrome (RPLS) is characterized by [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/34\">",
"     34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Headaches",
"     </li>",
"     <li>",
"      Altered consciousness",
"     </li>",
"     <li>",
"      Visual disturbances",
"     </li>",
"     <li>",
"      Seizures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The headache is typically constant, nonlocalized, moderate to severe, and unresponsive to analgesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Altered consciousness ranges from mild somnolence to confusion and agitation, progressing to stupor or coma in extreme cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,8,58,61\">",
"     1,8,58,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Seizures are often the presenting manifestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,46,62\">",
"     1,46,62",
"    </a>",
"    ]. Seizures are usually generalized tonic clonic; they may begin focally and often recur. Status epilepticus has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/59,63\">",
"     59,63",
"    </a>",
"    ]. Preceding visual loss or visual hallucinations suggest occipital lobe origin in some patients. Only a minority of patients, usually those with milder disease, are seizure free [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Visual perception abnormalities are often detectable. Hemianopia, visual neglect, auras, visual hallucinations, and cortical blindness may occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,64\">",
"     1,64",
"    </a>",
"    ]. The latter may be accompanied by denial of blindness (Anton's syndrome).",
"   </p>",
"   <p>",
"    The funduscopic examination is often normal, particularly in eclamptic and chronically hypertensive patients, but papilledema may be present with accompanying flame-shaped retinal hemorrhages and exudates. The deep tendon reflexes are frequently brisk with Babinski signs often present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/8\">",
"     8",
"    </a>",
"    ]. A few patients may have weakness and incoordination of the limbs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,6,65\">",
"     1,6,65",
"    </a>",
"    ]. Other focal neurologic deficits are rare.",
"   </p>",
"   <p>",
"    Hypertension is frequent but not invariable. The hypertensive crisis may precede the neurologic syndrome by 24 hours or longer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,8\">",
"     2,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     NEUROIMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroimaging is essential to the diagnosis of reversible posterior leukoencephalopathy syndrome (RPLS). Typical findings are symmetrical white matter edema in the posterior cerebral hemispheres, particularly the parieto-occipital regions, but variations do occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Because the neuroradiographic findings after seizures or other neurologic conditions can be similar to those seen in RPLS, repeat neuroimaging may be necessary. With treatment, resolution of findings on neuroimaging within days to weeks is expected.",
"   </p>",
"   <p>",
"    Some important localization considerations for RPLS are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The calcarine and paramedian parts of the occipital lobe are usually spared, helping to distinguish RPLS from bilateral posterior cerebral infarctions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Involvement of the cerebellum and brainstem is common. Isolated or predominant posterior fossa lesions, while uncommon, are increasingly described (sometimes called hypertensive brainstem encephalopathy) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,34,46,66-71\">",
"       2,34,46,66-71",
"      </a>",
"      ]. Rarely, changes are seen in the cervical spinal cord [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/72,73\">",
"       72,73",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lesions of the anterior cortex do occur but tend to occur in more severe cases, usually with edema being present in the posterior circulation territories [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,34,46\">",
"       2,34,46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Although abnormalities primarily affect the subcortical white matter, the cortex and basal ganglia may be involved [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/46,74,75\">",
"       46,74,75",
"      </a>",
"      ]. In some milder cases, abnormalities have been more predominantly seen in the gray matter suggesting that edema may begin in the cortex [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,66\">",
"       2,66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The distribution of abnormalities is usually not confined to a single vascular territory [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neuroradiographic abnormalities of RPLS are often apparent on computed tomography (CT) scans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/76\">",
"     76",
"    </a>",
"    ] but are best depicted by magnetic resonance imaging (MRI) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79338 \" href=\"mobipreview.htm?32/5/32854\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/18\">",
"     18",
"    </a>",
"    ]. The most commonly observed abnormalities on MRI are punctate or confluent areas of increased signal on proton density and T2-weighted images [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/33\">",
"     33",
"    </a>",
"    ]. Other typical MRI findings include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fluid-attenuated inversion recovery (FLAIR) sequences improve sensitivity and detect subtle peripheral lesions, showing cortical lesions to be more common than once thought by T2 imaging (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79338 \" href=\"mobipreview.htm?32/5/32854\">",
"       image 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,66\">",
"       2,66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Gyriform signal enhancement, reflecting disruption of the blood-brain barrier, can be present following the administration of gadolinium (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79338 \" href=\"mobipreview.htm?32/5/32854\">",
"       image 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Petechial and large parenchymal hemorrhages have also been described [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/18,46,76\">",
"       18,46,76",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In most follow-up studies, the abnormalities have partially or completely resolved suggesting edema rather than infarction (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56979 \" href=\"mobipreview.htm?13/3/13363\">",
"       image 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,33,46\">",
"       1,33,46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diffusion-weighted imaging (DWI) aids in the distinction of RPLS from top of the basilar stroke. Vasogenic edema is usually visualized as a hypo- or isointense signal on DWI (sometimes slightly hyperintense due to T2 shine through) and increased signal on apparent diffusion coefficient (ADC) maps (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56979 \" href=\"mobipreview.htm?13/3/13363\">",
"       image 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,7,66,74\">",
"       2,7,66,74",
"      </a>",
"      ]. Acute cerebral infarction produces marked hyperintensity on DWI and hypointensity on ADC maps (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef70704 \" href=\"mobipreview.htm?31/14/31974\">",
"       image 3",
"      </a>",
"      ). While patients with RPLS may have areas of signal abnormality consistent with ischemia, these are usually superimposed on areas of increased ADC values. Patients with areas of decreased ADC values usually, but not always, progress to true infarction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,6,12,66,77,78\">",
"       2,6,12,66,77,78",
"      </a>",
"      ]. A pseudonormalization of ADC values in areas of high DWI signal may be the earliest sign of permanent brain injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In one of the largest reported case series, the anatomical extent of MRI findings correlated with patient outcome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Prognosis'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Conventional angiography and magnetic resonance angiography (MRA) studies have documented vascular narrowing in patients with RPLS in a variety of clinical settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/79-86\">",
"     79-86",
"    </a>",
"    ]. This phenomenon is variably described as irregular in medium to large-sized vessels in some groups to diffuse and multisegmental in other groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/80\">",
"     80",
"    </a>",
"    ]. Prominent posterior circulation localization and reversibility of the findings are more consistently observed.",
"   </p>",
"   <p>",
"    More advanced neuroimaging modalities such as diffusion-tensor imaging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/13\">",
"     13",
"    </a>",
"    ], magnetic resonance spectroscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/87\">",
"     87",
"    </a>",
"    ], single-photon emission computed tomography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/18\">",
"     18",
"    </a>",
"    ], and perfusion-weighted MRI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/11\">",
"     11",
"    </a>",
"    ] show promise as diagnostic tools in the evaluation of RPLS, particularly in the assessment of prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific diagnostic criteria for reversible posterior leukoencephalopathy syndrome (RPLS). In the appropriate clinical setting, clinicians should recognize the neurologic syndrome of headache, visual symptoms, confusion, and seizures and order a brain MRI. Diffusion-weighted imaging (DWI) if available, adds considerable diagnostic and prognostic information. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Neuroimaging'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Because the neuroradiographic findings after seizures or other neurologic conditions can be similar to those seen in RPLS, repeat neuroimaging may be necessary. With treatment, resolution of findings on neuroimaging within days to weeks is expected. Atypical MRI findings and treatment failure should prompt consideration of other diagnoses. (See",
"    <a class=\"local\" href=\"#H38176987\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38176987\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical findings are not specific for reversible posterior leukoencephalopathy syndrome (RPLS), which can resemble other neurologic conditions, such as stroke, venous thrombosis, toxic or metabolic encephalopathy, demyelinating disorders, vasculitis, or encephalitis among others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/48,77,88\">",
"     48,77,88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Particularly in cases with a sudden onset of neurologic symptoms, the presentation can mimic bilateral posterior cerebral artery infarctions (\"top of the basilar syndrome\"). It is important to distinguish between RPLS and ischemic stroke, as the treatment of hypertension may be very different in these conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PREVENTION AND TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reversible posterior leukoencephalopathy syndrome (RPLS) should be promptly recognized, since it is usually reversible. Treating clinicians should have a high clinical suspicion in the appropriate settings (pregnancy, cytotoxic therapy, hypertensive patients), recognize the neurologic syndrome, and evaluate for RPLS with brain MRI.",
"   </p>",
"   <p>",
"    Because of the heterogeneous clinical settings in which RPLS occurs and because clinical reports are limited to case reports and small series, treatment recommendations are somewhat limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertension is a feature in the majority of RPLS patients, regardless of etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,19,83,84,89,90\">",
"     1,19,83,84,89,90",
"    </a>",
"    ]. With blood pressure lowering, patients will often improve dramatically. Except in cases of malignant hypertension, patients with RPLS often present with only moderate levels of hypertension; in the majority of cases, however, this still represents a significant increase above baseline levels.",
"   </p>",
"   <p>",
"    The initial aim of treatment in malignant hypertension is to rapidly lower the diastolic pressure to about 100 to 105 mmHg; this goal should be achieved within two to six hours, with the maximum initial fall in BP not exceeding 25 percent of the presenting value [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/91,92\">",
"     91,92",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    .) More aggressive blood pressure lowering is generally unnecessary and may reduce the blood pressure below the autoregulatory range, possibly leading to ischemic events (such as stroke or coronary disease) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with lower levels of hypertension, lowering blood pressure is also recommended to treat RPLS, but no specific guidelines are suggested as discussed for malignant hypertension above. Using clinical symptoms and any prior knowledge of baseline blood pressure as a guide, careful, incremental downward titration in 10 to 25 percent increments of the mean arterial blood pressure seems a reasonable approach.",
"   </p>",
"   <p>",
"    The use of easily titratable parenteral agents such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/61/42969?source=see_link\">",
"     nicardipine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35544?source=see_link\">",
"     labetalol",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    are effective and safe in reducing the blood pressure to a desirable range [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/94\">",
"     94",
"    </a>",
"    ]. One caveat to the acute use of nitroprusside is the theoretical concern that it may paradoxically increase intracranial pressure through vasodilatation. We now generally use nitroprusside only when nicardipine and labetalol are not available, contraindicated, or ineffective. The pharmacology and other side effects of these agents are reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/26/18853?source=see_link\">",
"     \"Drug treatment of hypertensive emergencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Oral antihypertensive agents have a slower onset of action and are not usually effective in consistently lowering the blood pressure to an appropriate range in hypertensive crises to prevent and treat RPLS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Except in the setting of eclampsia, most patients with RPLS and seizures are treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/6,8,63\">",
"     6,8,63",
"    </a>",
"    ]. Other antiepileptic drugs may be just as effective and may be preferred, depending on the patient's other comorbid medical conditions and prescribed drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/95\">",
"     95",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/4/31818?source=see_link\">",
"     \"Initial treatment of epilepsy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While long-term follow-up studies are lacking, there is no indication that these patients are at long-term risk for seizure recurrence or epilepsy. Although some case series report continuation of therapy for one to three months,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    can probably be safely tapered as symptoms and neuroimaging findings resolve, usually after one to two weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/63\">",
"     63",
"    </a>",
"    ]. In a few cases, recurrent seizures have reportedly occurred several months after an RPLS episode, and these patients were maintained on antiepileptic drug therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/94,96\">",
"     94,96",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Eclampsia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations for the treatment of eclampsia differ from RPLS in other clinical settings. Delivery of the baby and placenta is often sufficient. Magnesium is used to treat seizures and is superior to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    in this setting. The choice of antihypertensive drug is also influenced by concerns for placental function and fetal health. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/55/39801?source=see_link\">",
"     \"Eclampsia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=see_link\">",
"     \"Management of hypertension in pregnant and postpartum women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link\">",
"     \"Preeclampsia: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Cytotoxic immunosuppressive therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reduction in drug dosage or prompt removal of the cytotoxic drug is usually recommended in cases of RPLS associated with cytotoxic agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/97,98\">",
"     97,98",
"    </a>",
"    ]. However, cases are reported in which symptoms resolve while the medication is maintained [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/45\">",
"     45",
"    </a>",
"    ]. When another immunosuppressive agent is substituted, patients must be followed closely for recurrence of RPLS. It is not recommended that agents known to induce RPLS be reintroduced, as recurrence has been reported in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,50\">",
"     2,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on two cases and a literature review of RPLS in the setting of cytotoxic chemotherapy administration, authors suggest that patients with one or more of the following are at risk of RPLS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/99\">",
"     99",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Significant fluid overload (&gt;10 percent of baseline weight)",
"     </li>",
"     <li>",
"      Mean blood pressure &gt;25 percent of baseline",
"     </li>",
"     <li>",
"      Creatinine &gt;1.8",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (160",
"      <span class=\"nowrap\">",
"       &micro;mol/L)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In these patients, weight changes and blood pressure should be followed closely during aggressive fluid resuscitation (&gt;3 L of daily intravenous fluid). Although the number of cases was small, this marks one of the few attempts to focus on specific guidelines for treatment and may prove useful as a general means of preventing RPLS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because comorbid conditions including electrolyte disturbances, fluid overload, uremia, and sepsis are suggested to contribute to the development and prognosis in patients with RPLS, aggressive screening for and treatment of these conditions is recommended. In at least one case, aggressive dialysis appeared to influence the course of a patient with otherwise poor prognostic factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment of thrombotic thrombocytopenic purpura with plasmapheresis or immunoglobulin has resulted in resolution of RPLS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29721?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\", section on 'Neurologic symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with RPLS have been treated with decadron [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/6,100\">",
"     6,100",
"    </a>",
"    ], but because of its associated risk of hypertension, fluid overload, and electrolyte disturbance as well as the fact that high-dose steroid therapy has been associated with the development of RPLS, this is not a recommended therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most case series and case reports suggest that reversible posterior leukoencephalopathy syndrome (RPLS) is usually benign. In many cases, RPLS seems to be fully reversible within a period of days to weeks, after removal of the inciting factor and control of the blood pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1,40,41,61,101\">",
"     1,40,41,61,101",
"    </a>",
"    ]. Radiologic improvement lags behind clinical recovery.",
"   </p>",
"   <p>",
"    However, one of the largest case series reported highlights the potential grave consequences of this disorder; among 22 patients studied, six died and many survivors had permanent neurologic disability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"     2",
"    </a>",
"    ]. Death may result from progressive cerebral edema, intracerebral hemorrhage, or as a complication of the underlying condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2,6,8\">",
"     2,6,8",
"    </a>",
"    ]. In one series, elevated creatinine levels were a risk factor for death, but neither blood pressure levels or percent elevation from baseline values appeared to correlate with prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI findings of hyperintense signals on DWI and restricted diffusion on ADC mapping suggest cytotoxic as opposed to vasogenic edema; these findings seem to be predictive of irreversible infarction and in turn a worse prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"     2",
"    </a>",
"    ]. More extensive brain involvement, particularly in the brainstem also correlates with a worse prognosis.",
"   </p>",
"   <p>",
"    Recurrence of RPLS appears to be infrequent, 2 of 25 patients in one series, despite the fact that inciting factors commonly recur in these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/16/43273/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reversible posterior leukoencephalopathy syndrome (RPLS) is a neurologic syndrome defined by clinical and radiologic features.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The typical clinical syndrome includes headache, confusion, visual symptoms, and seizures. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Typical MRI findings are consistent with vasogenic edema and are predominantly localized to the posterior cerebral hemispheres. DWI can be helpful in distinguishing RPLS from stroke. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RPLS most often occurs in the setting of hypertensive crisis, preeclampsia, or with cytotoxic immunosuppressive therapy; however, many other clinical settings are described. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Associated conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend lowering blood pressure in all patients with RPLS (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). An easily titratable parenteral agent such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/61/42969?source=see_link\">",
"       nicardipine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35544?source=see_link\">",
"       labetalol",
"      </a>",
"      is suggested. Even patients with seemingly normal blood pressure benefit from blood pressure lowering as their baseline blood pressure may be much lower. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest withdrawing or lowering the dose of the offending cytotoxic agent, permanently if possible (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). When another immunosuppressive agent is substituted, patients must be followed closely for recurrence of RPLS. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Cytotoxic immunosuppressive therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest treating patients who have a seizure with antiepileptic drugs (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We typically use an intravenous agent such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      . The risk of late recurrence or epilepsy after uncomplicated RPLS appears low. As a result, we suggest that phenytoin be discontinued after symptoms and neuroimaging findings resolve (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Seizures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the partum or postpartum setting, we recommend treating patients with RPLS as though they have preeclampsia or eclampsia (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link\">",
"       \"Preeclampsia: Management and prognosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=see_link\">",
"       \"Management of hypertension in pregnant and postpartum women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/55/39801?source=see_link\">",
"       \"Eclampsia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Most patients recover within two weeks. A small number have residual neurologic deficits resulting from secondary cerebral infarction or hemorrhage; some patients die as a result of increased intracranial pressure or as a complication of the underlying condition. MRI findings can be helpful in identifying patients with worse prognosis. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/1\">",
"      Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/2\">",
"      Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002; 23:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/3\">",
"      Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001; 24:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/4\">",
"      Antunes NL, Small TN, George D, et al. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999; 20:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/5\">",
"      Alehan F, Erol I, Agildere AM, et al. Posterior leukoencephalopathy syndrome in children and adolescents. J Child Neurol 2007; 22:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/6\">",
"      Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998; 51:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/7\">",
"      Provenzale JM, Petrella JR, Cruz LC Jr, et al. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2001; 22:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/8\">",
"      Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005; 35:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/9\">",
"      Strandgaard S, Paulson OB. Cerebral autoregulation. Stroke 1984; 15:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/10\">",
"      Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990; 2:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/11\">",
"      Jones BV, Egelhoff JC, Patterson RJ. Hypertensive encephalopathy in children. AJNR Am J Neuroradiol 1997; 18:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/12\">",
"      Koch S, Rabinstein A, Falcone S, Forteza A. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. AJNR Am J Neuroradiol 2001; 22:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/13\">",
"      Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001; 219:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/14\">",
"      Lewis LK, Hinshaw DB Jr, Will AD, et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988; 30:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/15\">",
"      Naidu K, Moodley J, Corr P, Hoffmann M. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997; 104:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/16\">",
"      Tajima Y, Isonishi K, Kashiwaba T, Tashiro K. Two similar cases of encephalopathy, possibly a reversible posterior leukoencephalopathy syndrome: serial findings of magnetic resonance imaging, SPECT and angiography. Intern Med 1999; 38:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/17\">",
"      Lanzino G, Cloft H, Hemstreet MK, et al. Reversible posterior leukoencephalopathy following organ transplantation. Description of two cases. Clin Neurol Neurosurg 1997; 99:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/18\">",
"      Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992; 159:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/19\">",
"      Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998; 19:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/20\">",
"      Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000; 217:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/21\">",
"      Savvidou MD, Hingorani AD, Tsikas D, et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003; 361:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/22\">",
"      Easton JD. Severe preeclampsia/eclampsia: hypertensive encephalopathy of pregnancy? Cerebrovasc Dis 1998; 8:53.",
"     </a>",
"    </li>",
"    <li>",
"     Lindenbaum, J. An approach to the anemias. In: Cecil's textbook of medicine, Bennett, JC, Plum, F (Eds), Saunders, Philadelphia 1996. p.823.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/24\">",
"      Rodgers GM, Taylor RN, Roberts JM. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/25\">",
"      Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995; 90:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/26\">",
"      Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/27\">",
"      Burrus TM, Mandrekar J, Wijdicks EF, Rabinstein AA. Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura. Arch Neurol 2010; 67:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/28\">",
"      Hawley JS, Ney JP, Swanberg MM. Thrombotic thrombocytopenic purpura-induced posterior leukoencephalopathy in a patient without significant renal or hypertensive complications. J Postgrad Med 2004; 50:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/29\">",
"      Brightman MW, Klatzo I, Olsson Y, Reese TS. The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci 1970; 10:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/30\">",
"      Kalimo H, Fredriksson K, Nordborg C, et al. The spread of brain oedema in hypertensive brain injury. Med Biol 1986; 64:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/31\">",
"      Beausang-Linder M, Bill A. Cerebral circulation in acute arterial hypertension--protective effects of sympathetic nervous activity. Acta Physiol Scand 1981; 111:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/32\">",
"      Edvinsson L, Owman C, Sj&ouml;berg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 1976; 115:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/33\">",
"      Lamy C, Oppenheim C, M&eacute;der JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004; 14:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/34\">",
"      Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010; 85:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/35\">",
"      Maga&ntilde;a SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009; 72:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/36\">",
"      Barton JR, Sibai BM. Cerebral pathology in eclampsia. Clin Perinatol 1991; 18:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/37\">",
"      Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997; 28:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/38\">",
"      Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 1998; 19:859.",
"     </a>",
"    </li>",
"    <li>",
"     Lamy, C, Mas, JL. Hypertensive encephalopathy. In: Stroke: Pathophysiology, Diagnosis, and Management, 4th ed, Mohr, JP, Choi, D, Grotta J, et al (Eds), Churchill Livingstone, New York 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/40\">",
"      Leroux G, Sellam J, Costedoat-Chalumeau N, et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 2008; 17:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/41\">",
"      Mak A, Chan BP, Yeh IB, et al. Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma. Rheumatology (Oxford) 2008; 47:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/42\">",
"      Hodson AK, Doughty RA, Norman ME. Acute encephalopathy, streptococcal infection, and cryoglobulinemia. Arch Neurol 1978; 35:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/43\">",
"      Port JD, Beauchamp NJ Jr. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 1998; 18:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/44\">",
"      Magnano MD, Bush TM, Herrera I, Altman RD. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 2006; 35:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/45\">",
"      Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995; 165:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/46\">",
"      Dinsdale HB. Hypertensive encephalopathy. Neurol Clin 1983; 1:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/47\">",
"      Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J 2001; 77:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/48\">",
"      Raps EC, Galetta SL, Broderick M, Atlas SW. Delayed peripartum vasculopathy: cerebral eclampsia revisited. Ann Neurol 1993; 33:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/49\">",
"      Ille O, Woimant F, Pruna A, et al. Hypertensive encephalopathy after bilateral carotid endarterectomy. Stroke 1995; 26:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/50\">",
"      Serkova NJ, Christians U, Benet LZ. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 2004; 4:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/51\">",
"      Kou R, Greif D, Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 2002; 277:29669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/52\">",
"      Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998; 1366:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/53\">",
"      Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006; 354:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/54\">",
"      Ozcan C, Wong SJ, Hari P. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006; 354:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/55\">",
"      Allen JA, Adlakha A, Bergethon PR. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol 2006; 63:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/56\">",
"      Bodkin CL, Eidelman BH. Sirolimus-induced posterior reversible encephalopathy. Neurology 2007; 68:2039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/57\">",
"      Rajasekhar A, George TJ Jr. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Oncologist 2007; 12:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/58\">",
"      Junna MR, Rabinstein AA. Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma. J Neurol Neurosurg Psychiatry 2007; 78:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/59\">",
"      Kozak OS, Wijdicks EF, Manno EM, et al. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 2007; 69:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/60\">",
"      Seet RC, Rabinstein AA. Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment. QJM 2012; 105:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/61\">",
"      Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008; 65:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/62\">",
"      Kastrup O, Gerwig M, Frings M, Diener HC. Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns. J Neurol 2012; 259:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/63\">",
"      Bakshi R, Bates VE, Mechtler LL, et al. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia 1998; 39:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/64\">",
"      Lysandropoulos AP, Rossetti AO. Postictal cortical visual impairment: a symptom of posterior reversible encephalopathy. Epilepsy Behav 2010; 17:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/65\">",
"      Keswani SC, Wityk R. Don't throw in the towel! A case of reversible coma. J Neurol Neurosurg Psychiatry 2002; 73:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/66\">",
"      Wang MC, Escott EJ, Breeze RE. Posterior fossa swelling and hydrocephalus resulting from hypertensive encephalopathy: case report and review of the literature. Neurosurgery 1999; 44:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/67\">",
"      de Seze J, Mastain B, Stojkovic T, et al. Unusual MR findings of the brain stem in arterial hypertension. AJNR Am J Neuroradiol 2000; 21:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/68\">",
"      Oliviero, PJ, Restrepo, L, Mitchell, SA, et al. Reversible tacrolimus-induced neurotoxicity isolated to the brainstem. Am J Neuroradiol 2000; 21:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/69\">",
"      Kitaguchi H, Tomimoto H, Miki Y, et al. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology 2005; 47:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/70\">",
"      Meylaerts L, Ooms V, Lyra S, et al. Hypertensive brain stem encephalopathy in a patient with chronic renal failure. Clin Nephrol 2006; 65:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/71\">",
"      Friese S, Fetter M, K&uuml;ker W. Extensive brainstem edema in eclampsia: diffusion-weighted MRI may indicate a favorable prognosis. J Neurol 2000; 247:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/72\">",
"      Lapuyade B, Sibon I, Jeanin S, Dousset V. Neurological picture. Spinal cord involvement in posterior reversible encephalopathy syndrome. J Neurol Neurosurg Psychiatry 2009; 80:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/73\">",
"      Briganti C, Caulo M, Notturno F, et al. Asymptomatic spinal cord involvement in posterior reversible encephalopathy syndrome. Neurology 2009; 73:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/74\">",
"      Digre KB, Varner MW, Osborn AG, Crawford S. Cranial magnetic resonance imaging in severe preeclampsia vs eclampsia. Arch Neurol 1993; 50:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/75\">",
"      Weingarten K, Barbut D, Filippi C, Zimmerman RD. Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging. AJR Am J Roentgenol 1994; 162:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/76\">",
"      Oppenheim C, Logak M, Dormont D, et al. Diagnosis of acute ischaemic stroke with fluid-attenuated inversion recovery and diffusion-weighted sequences. Neuroradiology 2000; 42:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/77\">",
"      Oppenheim C, Galanaud D, Samson Y, et al. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 2000; 69:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/78\">",
"      Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988; 19:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/79\">",
"      Heo K, Park S, Lee JY, et al. Post-transfusion posterior leukoencephalopathy with cytotoxic and vasogenic edema precipitated by vasospasm. Cerebrovasc Dis 2003; 15:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/80\">",
"      Will AD, Lewis KL, Hinshaw DB Jr, et al. Cerebral vasoconstriction in toxemia. Neurology 1987; 37:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/81\">",
"      Kaplan PW. Reversible hypercalcemic cerebral vasoconstriction with seizures and blindness: a paradigm for eclampsia? Clin Electroencephalogr 1998; 29:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/82\">",
"      Voltz R, Rosen FV, Yousry T, et al. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barr&eacute; syndrome patient treated with intravenous immunoglobulin. Neurology 1996; 46:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/83\">",
"      Henderson RD, Rajah T, Nicol AJ, Read SJ. Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 2003; 60:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/84\">",
"      Ito Y, Niwa H, Iida T, et al. Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 1997; 49:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/85\">",
"      Boughammoura A, Touz&eacute; E, Oppenheim C, et al. Reversible angiopathy and encephalopathy after blood transfusion. J Neurol 2003; 250:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/86\">",
"      Eichler FS, Wang P, Wityk RJ, et al. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 2002; 23:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/87\">",
"      Delanty N, Vaughan C, Frucht S, Stubgen P. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997; 49:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/88\">",
"      Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000; 21:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/89\">",
"      Kupferschmidt H, Bont A, Schnorf H, et al. Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med 1995; 123:598.",
"     </a>",
"    </li>",
"    <li>",
"     Kaplan, NM. Hypertensive crises. In: Clinical Hypertension, 7th ed, Kaplan, NM (Ed), Williams &amp; Wilkins, Baltimore 1998. p.265.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/91\">",
"      Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000; 356:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/92\">",
"      Ledingham JG, Rajagopalan B. Cerebral complications in the treatment of accelerated hypertension. Q J Med 1979; 48:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/93\">",
"      Neutel JM, Smith DH, Wallin D, et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens 1994; 7:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/94\">",
"      Arnoldus EP, Van Laar T. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:1745; author reply 1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/95\">",
"      Eberly AL, Anderson GD, Bubalo JS, McCune JS. Optimal prevention of seizures induced by high-dose busulfan. Pharmacotherapy 2008; 28:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/96\">",
"      Baldini M, Bartolini E, Gori S, et al. Epilepsy after neuroimaging normalization in a woman with tacrolimus-related posterior reversible encephalopathy syndrome. Epilepsy Behav 2010; 17:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/97\">",
"      Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999; 246:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/98\">",
"      Hauben M. Cyclosporine neurotoxicity. Pharmacotherapy 1996; 16:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/99\">",
"      Tam CS, Galanos J, Seymour JF, et al. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol 2004; 77:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/100\">",
"      Eaton JM. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/16/43273/abstract/101\">",
"      Roth C, Ferbert A. Posterior reversible encephalopathy syndrome: long-term follow-up. J Neurol Neurosurg Psychiatry 2010; 81:773.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4835 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-FFFC22E1CE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43273=[""].join("\n");
var outline_f42_16_43273=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Autoregulatory failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cerebral ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Endothelial dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other mechanisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Anatomic distribution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ASSOCIATED CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hypertensive encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Eclampsia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Immunosuppressive therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      NEUROIMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H38176987\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PREVENTION AND TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Eclampsia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Cytotoxic immunosuppressive therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/4835\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4835|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?32/5/32854\" title=\"diagnostic image 1\">",
"      RPL CT and MRI findings A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?13/3/13363\" title=\"diagnostic image 2\">",
"      RPL CT and MRI findings B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?31/14/31974\" title=\"diagnostic image 3\">",
"      Distal basilar artery embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4835|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/2/18477\" title=\"figure 1\">",
"      Norm autoregulation cereb",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/13/34013\" title=\"figure 2\">",
"      Cerebral autoregulation in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4835|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/50/22316\" title=\"table 1\">",
"      Medical conditions with RPLS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29721?source=related_link\">",
"      Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/26/18853?source=related_link\">",
"      Drug treatment of hypertensive emergencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/55/39801?source=related_link\">",
"      Eclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/4/31818?source=related_link\">",
"      Initial treatment of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41398?source=related_link\">",
"      Malignant hypertension and hypertensive encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=related_link\">",
"      Management of hypertension in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34777?source=related_link\">",
"      Pathogenesis of preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=related_link\">",
"      Pharmacology and side effects of cyclosporine and tacrolimus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=related_link\">",
"      Preeclampsia: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43882?source=related_link\">",
"      Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_16_43274="Basic case 13";
var content_f42_16_43274=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51524&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51524&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1252px;\">",
"  <div class=\"figure\" style=\"width: 538px\">",
"   <div class=\"ttl\">",
"    Basic case 13",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 518px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43274=[""].join("\n");
var outline_f42_16_43274=null;
var title_f42_16_43275="Air embolism conditions";
var content_f42_16_43275=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Conditions associated with air embolism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Surgical procedures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurosurgery (craniotomy, shunt placement)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Otolaryngological procedures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Orthopedic surgery (arthroscopy, endoprosthesis placement)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ob-Gyn procedures (hysteroscopy/laparoscopy, cesarean section)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiothoracic surgery (cardiopulmonary bypass, lung resection, YAG laser resection, lung transplantation, needle biopsy of lung)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Intravenous catheterization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Central lines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemodialysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CABG/angioplasty",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pacemaker or defibrillator placement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radiofrequency cardiac ablation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Radiologic procedures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intravenous contrast injection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arthrography",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Head and neck injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Penetrating and blunt chest trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blunt abdominal trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Positive pressure ventilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Decompression sickness",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43275=[""].join("\n");
var outline_f42_16_43275=null;
var title_f42_16_43276="Skin lesions and rashes in coma";
var content_f42_16_43276=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F79446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F79446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Skin lesions and rashes in coma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Lesion or rash",
"      </td>",
"      <td class=\"subtitle1\">",
"       Possible cause",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antecubital needle marks",
"      </td>",
"      <td>",
"       Opiate drug abuse",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pale skin",
"      </td>",
"      <td>",
"       Anemia or hemorrhage",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Sallow, puffy appearance",
"      </td>",
"      <td>",
"       Hypopituitarism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hypermelanosis (increased pigment)",
"      </td>",
"      <td>",
"       Porphyria, Addison's disease, chronic nutritional deficiency, disseminated malignant melanoma, chemotherapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Generalized cyanosis",
"      </td>",
"      <td>",
"       Hypoxemia or carbon dioxide poisoning",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Grayish-blue cyanosis",
"      </td>",
"      <td>",
"       Methemoglobin (analine or nitrobenzene) intoxication",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Localized cyanosis",
"      </td>",
"      <td>",
"       Arterial emboli or vasculitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cherry-red skin",
"      </td>",
"      <td>",
"       Carbon monoxide poisoning",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Icterus",
"      </td>",
"      <td>",
"       Hepatic dysfunction or hemolytic anemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Petechiae",
"      </td>",
"      <td>",
"       Disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, drugs",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ecchymosis",
"      </td>",
"      <td>",
"       Trauma, corticosteroid use, abnormal coagulation from liver disease or anticoagulants",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Telangiectasia",
"      </td>",
"      <td>",
"       Chronic alcoholism, occasionally vascular malformations of the brain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Vesicular rash",
"      </td>",
"      <td>",
"       Herpes simplex, varicella, Bechet's disease, or drugs",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Petechial-purpuric rash",
"      </td>",
"      <td>",
"       Meningococcemia, other bacterial sepsis (rarely), gonococcemia, staphylococcemia, pseudomonas, subacute bacterial endocarditis, allergic vasculitis, purpura fulminans, Rocky Mountain spotted fever, typhus, fat emboli",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Macular-papular rash",
"      </td>",
"      <td>",
"       Typhus, candida, cryptococcus, toxoplasmosis, subacute bacterial endocarditis, staphylococcal toxic shock, typhoid, leptospirosis, pseudomona sepsis, immunological disorders (systemic lupus erythematosus, dermatomyositis, serum sickness)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ecthyma gangrenosum",
"      </td>",
"      <td>",
"       Necrotic eschar often seen in the anogenital or axillary area in Pseudomonas sepsis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Splinter hemorrhages",
"      </td>",
"      <td>",
"       Linear hemorrhages under the nail, seen in subacute bacterial endocarditis, anemia, leukemia, and sepsis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Osler's nodes",
"      </td>",
"      <td>",
"       Purplish or erythematous painful, tender nodules on palms and soles, seen in subacute bacterial endocarditis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Gangrene of digits' extremities",
"      </td>",
"      <td>",
"       Emboli to larger peripheral arteries",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pigmented macules",
"      </td>",
"      <td>",
"       Tuberous sclerosis, neurofibromatosis",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Berger, Joseph R. Clinical Approach to Stupor and Coma. In: Neurology in Clinical Practice: Principles of Diagnosis and Mangement, 4th ed, Bradley, WG, Daroff, RB, Fenichel, GM, Jankovic, J (Eds), Butterworth Heinmann, Philadelphia, PA 2004. p.51. Copyright &copy; 2004 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43276=[""].join("\n");
var outline_f42_16_43276=null;
var title_f42_16_43277="Alendronate prevents bone loss";
var content_f42_16_43277=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F72430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F72430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alendronate prevents bone loss at the hip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 417px; height: 228px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone mineral density at the hip increased during two years of treatment with aldendronate, while decreasing in those receiving placebo. Women treated with 5 mg of alendronate had greater increases in bone mineral density than those treated with 2.5 mg, and slightly smaller increases than women receiving estrogen and progestin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.&nbsp;N Engl J Med 1998; 338:485.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43277=[""].join("\n");
var outline_f42_16_43277=null;
var title_f42_16_43278="NuvaRing hand squeezing PI";
var content_f42_16_43278=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F73663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F73663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    NuvaRing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 302px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This ring stays inside the vagina for 3 weeks at a time. It delivers hormones into the body that help prevent pregnancy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.nuvaring.com. Copyright &copy; 2004 Organon USA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43278=[""].join("\n");
var outline_f42_16_43278=null;
var title_f42_16_43279="HDV virion";
var content_f42_16_43279=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F63575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F63575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 480px\">",
"   <div class=\"ttl\">",
"    HDV virion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 460px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the hepatitis D virus virion. The HD virion comprises an RNA genome, a single HDV encoded antigen, and a lipoprotein envelope provided by HBV.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_16_43279=[""].join("\n");
var outline_f42_16_43279=null;
               